<!DOCTYPE article
 PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="preprint"><?all-math-mml yes?><?use-mml?><?origin ukpmcpa?><front><journal-meta><journal-id journal-id-type="nlm-ta">bioRxiv</journal-id><journal-title-group><journal-title>bioRxiv : the preprint server for biology</journal-title></journal-title-group><issn pub-type="ppub"/></journal-meta><article-meta><article-id pub-id-type="manuscript">EMS190329</article-id><article-id pub-id-type="doi">10.1101/2023.10.27.564358</article-id><article-id pub-id-type="archive">PPR749169</article-id><article-version-alternatives><article-version article-version-type="status">preprint</article-version><article-version article-version-type="number">1</article-version></article-version-alternatives><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>ATAC and SAGA histone acetyltransferase modules facilitate transcription factor binding to nucleosomes in an acetylation independent manner</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Chesnutt</surname><given-names>Kristin</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Yayli</surname><given-names>Gizem</given-names></name><xref ref-type="aff" rid="A2">2</xref><xref ref-type="aff" rid="A3">3</xref><xref ref-type="aff" rid="A4">4</xref><xref ref-type="aff" rid="A5">5</xref></contrib><contrib contrib-type="author"><name><surname>Toelzer</surname><given-names>Christine</given-names></name><xref ref-type="aff" rid="A6">6</xref></contrib><contrib contrib-type="author"><name><surname>Cox</surname><given-names>Khan</given-names></name><xref ref-type="aff" rid="A7">7</xref></contrib><contrib contrib-type="author"><name><surname>Gautam</surname><given-names>Gunjan</given-names></name><xref ref-type="aff" rid="A6">6</xref></contrib><contrib contrib-type="author"><name><surname>Berger</surname><given-names>Imre</given-names></name><xref ref-type="aff" rid="A6">6</xref></contrib><contrib contrib-type="author"><name><surname>Tora</surname><given-names>László</given-names></name><xref ref-type="aff" rid="A2">2</xref><xref ref-type="aff" rid="A3">3</xref><xref ref-type="aff" rid="A4">4</xref><xref ref-type="aff" rid="A5">5</xref><xref ref-type="corresp" rid="CR1">*</xref></contrib><contrib contrib-type="author"><name><surname>Poirier</surname><given-names>Michael G.</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A7">7</xref><xref ref-type="aff" rid="A8">8</xref><xref ref-type="corresp" rid="CR1">*</xref></contrib></contrib-group><aff id="A1"><label>1</label>Ohio State Biochemistry Program, Ohio State University, Columbus, USA</aff><aff id="A2"><label>2</label>Institut de Génétique et de Biologie Moléculaire et Cellulaire, Illkirch, France</aff><aff id="A3"><label>3</label>Centre National de la Recherche Scientifique, UMR7104, Illkirch, France</aff><aff id="A4"><label>4</label>Institut National de la Santé et de la Recherche Médicale, U1258, Illkirch, France</aff><aff id="A5"><label>5</label>Université de Strasbourg, Illkirch, France</aff><aff id="A6"><label>6</label>Bristol University, Bristol, UK</aff><aff id="A7"><label>7</label>Department of Physics, Ohio State University, Columbus, USA</aff><aff id="A8"><label>8</label>Department of Chemistry &amp; Biochemistry, Ohio State University, Columbus, USA</aff><author-notes><corresp id="CR1">
<label>*</label>Correspondence should be addressed to M.G.P. <email>poirier.18@osu.edu</email> and/or L.T. <email>laszlo@igbmc.fr</email>
</corresp></author-notes><pub-date pub-type="nihms-submitted"><day>31</day><month>10</month><year>2023</year></pub-date><pub-date pub-type="preprint"><day>27</day><month>10</month><year>2023</year></pub-date><permissions><ali:free_to_read/><license><ali:license_ref>https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">CC BY-NC-ND 4.0 International license</ext-link>.</license-p></license></permissions><abstract><title>Summary</title><p id="P1">Transcription initiation involves the coordination of multiple events, starting with activators binding specific DNA target sequences, which recruits transcription co-activators to open chromatin and enable binding of general transcription factors and RNA polymerase II to promoters. Two key human transcriptional coactivator complexes, ATAC (ADA-Two-A-Containing) and SAGA (Spt-Ada-Gcn5-acetyltransferase), target genomic loci to increase promoter accessibility. To better understand the function of ATAC and SAGA histone acetyltransferase (HAT) complexes, we used <italic>in vitro</italic> biochemical and biophysical assays to characterize human ATAC and SAGA HAT module interactions with nucleosomes and how a transcription factor (TF) coordinates these interactions. We found that ATAC and SAGA HAT modules bind nucleosomes with high affinity, independent of post-translational modifications (PTMs) and TFs. ATAC and SAGA HAT modules directly interact with the VP16 activator domain and a TF containing this domain enhances HAT module acetylation activity. Surprisingly, ATAC and SAGA HAT modules increase TF binding to its DNA target site within the nucleosome by an order of magnitude independent of histone acetylation. Altogether, our results reveal synergistic coordination between HAT modules and a TF, where ATAC and SAGA HAT modules: (i) acetylate histones to open chromatin, and (ii) facilitate TF targeting within nucleosomes independently of their acetylation activity.</p></abstract><kwd-group><kwd>lysine acetylation</kwd><kwd>transcription regulation</kwd><kwd>nucleosome dynamics</kwd><kwd>transcription factors</kwd><kwd>transcription co-activators</kwd></kwd-group></article-meta></front><body><sec id="S1" sec-type="intro"><title>Introduction</title><p id="P2">The eukaryotic genome is packaged in the nucleus as a highly condensed structure called chromatin. The basic repeating unit of chromatin is the nucleosome, which contains ~147 base pairs (bp) of DNA wrapped ~1.65 times around two copies of each histone protein (H2A, H2B, H3, and H4) (<xref ref-type="bibr" rid="R1">1</xref>–<xref ref-type="bibr" rid="R3">3</xref>). Human genomic DNA is wrapped into ~20 million nucleosomes, which compact into dynamic higher-order structures that regulate DNA accessibility and controls genome functions, including transcription and DNA repair/replication (<xref ref-type="bibr" rid="R4">4</xref>, <xref ref-type="bibr" rid="R5">5</xref>). Access to DNA is critical for DNA-mediated events (<xref ref-type="bibr" rid="R6">6</xref>). For example, transcription factors (TFs) must access specific DNA target sequences within promoters and enhancers to initiate the activation of genes by facilitating the recruitment of co-activators, including chromatin-modifying complexes (<xref ref-type="bibr" rid="R7">7</xref>, <xref ref-type="bibr" rid="R8">8</xref>). However, the mechanisms by which TFs and chromatin-modifying complexes coordinate their gene-activating functions are not yet fully understood.</p><p id="P3">Chromatin-modifying complexes recognize (readers), deposit (writers) and remove (erasers) post-translational modifications (PTMs) of histones in a dynamic manner. Two highly conserved large multi-subunit transcriptional regulatory co-activator complexes that can acetylate histones at distinct residues are ATAC (ADA-Two-A-Containing) and SAGA (Spt-Ada-Gcn5-acetyltransferase) (<xref ref-type="bibr" rid="R9">9</xref>).</p><p id="P4">The metazoan ATAC and SAGA coactivator complexes contain 10 and 18-20 well-characterized subunits, respectively, which are organized in functional modules (<xref ref-type="bibr" rid="R10">10</xref>–<xref ref-type="bibr" rid="R12">12</xref>). SAGA is conserved from yeast to humans and organized into the histone acetyltransferase (HAT), histone H2Bub1 deubiquitinase (DUB), activator binding (AM), splicing (SM) and core modules (<xref ref-type="bibr" rid="R10">10</xref>–<xref ref-type="bibr" rid="R16">16</xref>). ATAC, which has been described in metazoans but is not found in yeast, also contains a HAT module (<xref ref-type="bibr" rid="R17">17</xref>) and a core module (<xref ref-type="bibr" rid="R18">18</xref>); however, the structural organization of ATAC is not yet known.</p><p id="P5">Importantly, ATAC and SAGA HAT modules (hereafter ATAC<sub>HAT</sub> and SAGA<sub>HAT</sub>) are highly similar in that three of their subunits KAT2A/KAT2B, TADA3 and SGF29 are shared between them. The fourth and distinctive subunit is either TADA2A, or TADA2B for ATAC, or SAGA HAT modules, respectively (<xref ref-type="fig" rid="F1">Figure 1A</xref>) (<xref ref-type="bibr" rid="R12">12</xref>, <xref ref-type="bibr" rid="R19">19</xref>, <xref ref-type="bibr" rid="R20">20</xref>). The similar HAT modules of these two endogenous co-activator complexes seem to have different histone acetylation targets <italic>in vivo</italic>, where SAGA acetylates H3K9 and H3K14 (<xref ref-type="bibr" rid="R17">17</xref>, <xref ref-type="bibr" rid="R21">21</xref>, <xref ref-type="bibr" rid="R22">22</xref>), while it has been suggested that ATAC acetylates both histone H3 and H4 (<xref ref-type="bibr" rid="R16">16</xref>, <xref ref-type="bibr" rid="R23">23</xref>–<xref ref-type="bibr" rid="R27">27</xref>). In addition, ATAC and SAGA play different regulatory roles in transcription regulation and/or cellular homeostasis (<xref ref-type="bibr" rid="R25">25</xref>, <xref ref-type="bibr" rid="R27">27</xref>–<xref ref-type="bibr" rid="R34">34</xref>). How these two coactivator complexes containing very similar HAT modules target histone acetylation differentially remains an open question.</p><p id="P6">Recent cryo-EM studies (<xref ref-type="bibr" rid="R15">15</xref>, <xref ref-type="bibr" rid="R16">16</xref>, <xref ref-type="bibr" rid="R35">35</xref>) have revealed the structure of most of the SAGA complex at high resolution. However, SAGA<sub>HAT</sub> could not be resolved in the structures, indicating that the module has a high degree of flexibility within the SAGA complex. This flexibility is further enhanced by nucleosome binding, which appears to result in the displacement of the HAT module (<xref ref-type="bibr" rid="R16">16</xref>). In addition, a metazoan SAGA<sub>HAT</sub> has been reported to function on its own as the ADA complex (<xref ref-type="bibr" rid="R36">36</xref>) and with the addition of the protein Chiffon (<xref ref-type="bibr" rid="R37">37</xref>).</p><p id="P7">Targeting of the SAGA complex by TFs occurs at least in part through interactions with the AM module, which in humans is TRRAP (<xref ref-type="bibr" rid="R36">36</xref>, <xref ref-type="bibr" rid="R38">38</xref>). In addition, Myc has been described to interact directly with TRRAP and KAT2A (<xref ref-type="bibr" rid="R39">39</xref>–<xref ref-type="bibr" rid="R42">42</xref>). Interestingly, the SAGA<sub>HAT</sub> module has a number of nucleosome binding domains indicating that it can target nucleosomes directly (<xref ref-type="bibr" rid="R10">10</xref>). This in combination with the observation that the AM module is not included in the ATAC complex, nor in the ADA complex, raises questions about how TFs target these endogenous co-activator complexes to chromatin.</p><p id="P8">Uncovering how these human HAT modules engage with TFs to target, acetylate and open chromatin is important for understanding mechanisms by which these co-activator complexes function to facilitate transcription initiation. Here we report systematic biochemical and biophysical studies of the interactions of SAGA<sub>HAT</sub> and ATAC<sub>HAT</sub> with the activator Gal4-VP16 and nucleosomes that contain the Gal4 target sequence. We find that both HAT modules directly interact strongly with nucleosomes and the VP16 activator. We then asked how the chimeric TF, Gal4-VP16, functions with each HAT module to open and acetylate nucleosomes. We focused on the Gal4 target site located in the nucleosome entry-exit region, a common position for TF binding sites (<xref ref-type="bibr" rid="R43">43</xref>–<xref ref-type="bibr" rid="R45">45</xref>). We determined that Gal4-VP16 significantly enhances histone acetylation of both ATAC<sub>HAT</sub> and SAGA<sub>HAT</sub>, with a larger impact on ATAC<sub>HAT</sub>, and that this depends on the VP16 activator domain (AD). We then investigated the impact of each HAT module on Gal4-VP16 binding to its target site within nucleosomes. Interestingly, we found that both ATAC<sub>HAT</sub> and SAGA<sub>HAT</sub> increase Gal4-VP16 binding by an order of magnitude, but these increases did not depend on the histone acetylation activity of either complex. These results indicate that both ATAC<sub>HAT</sub> and SAGA<sub>HAT</sub> function with TFs to not only acetylate nucleosomes, but they also facilitate TF binding within nucleosomes independent of their histone acetylation activity.</p></sec><sec id="S2" sec-type="materials | methods"><title>Material and Methods</title><sec id="S3"><title>DNA preparation and purification</title><p id="P9">DNA constructs for reconstituting nucleosomes for FRET and acetylation assay experiments were prepared using PCR with Cy3-labeled oligonucleotides and a plasmid containing the Widom 601 nucleosome positioning sequence (NPS) with the Gal4 binding site (5’-CCGGAGGGCTGCCCTCCGG-3’) at bases 8-26 (<xref ref-type="bibr" rid="R46">46</xref>–<xref ref-type="bibr" rid="R48">48</xref>). Oligonucleotides were labeled with Cy3 NHS ester (GE Healthcare) at an amine-modified internal thymine and HPLC purified on a 218TP C18 reverse-phase column (Grace/Vydac) as previously described (<xref ref-type="bibr" rid="R49">49</xref>). DNA constructs for reconstituting nucleosomes for Fluorescence Anisotropy were prepared using PCR with Fluorescein-labeled oligonucleotides and a plasmid containing the Widom 601 nucleosome positioning sequence (NPS). Following PCR amplification, DNA was purified using a MonoQ column (GE healthcare).</p></sec><sec id="S4"><title>Core histone expression, purification, and histone octamer preparation</title><p id="P10">The histone octamer was prepared as previously described (<xref ref-type="bibr" rid="R49">49</xref>). Human histones: H2A(K119C), H2B, H3, and H4 were purchase from Histone Source. Lyophilized histones were resuspended in unfolding buffer (20 mM Tris-HCL pH 7.5, 7 M guanidinium, and 10 mM DTT) at 5 mg/ml for 1 hr then spun to remove aggregates. To determine concentration, absorption at 276 nm was measured for each unfolded histone. Histone octamers were refolded by combining (H2A and H2B):(H3 and H4) together at a ratio of 1.2:1. Double dialysis was performed to form the histone octamer into refolding buffer (10 mM Tris-HCl pH 7.5, 1 mM EDTA, 2 M NaCl, and 5 mM BME). The octamer was removed from dialysis and labeled with Cy5 maleimide (GE healthcare) at H2A(K119C) as previously described (<xref ref-type="bibr" rid="R50">50</xref>, <xref ref-type="bibr" rid="R51">51</xref>). Labeled octamer was purified over a Superdex 200 (GE Healthcare) gel filtration column to remove excess dimer, tetramer, and dye. Labeling efficiency was determined by Ultraviolet-visible (UV-Vis) absorption, and purity of each octamer was confirmed by SDS-PAGE (<xref ref-type="supplementary-material" rid="SD1">Supplementary Figure S1</xref>).</p></sec><sec id="S5"><title>Nucleosome preparation</title><p id="P11">Nucleosomes were reconstituted and purified as previously described (<xref ref-type="bibr" rid="R49">49</xref>, <xref ref-type="bibr" rid="R52">52</xref>). DNA and histone octamers were combined at a ratio of 1.25:1 in high salt refolding buffer (0.5x TE pH 8.0, 2 M NaCl, 0.5 mM EDTA and 1 mM benzamidine−HCl) and reconstituted using double dialysis with 4 L of reconstitution buffer at 4 °C for 5-6 h and then changed into a new 4 L bucket of buffer at 4 °C overnight (0.5x TE pH 8.0, 0.5 mM EDTA, 1 mM benzamidine−HCl). Dialyzed nucleosomes were purified in a 5-30% w/v sucrose gradient with a SW41 Ti (Beckman Coulter) rotor in an Optima L-90K ultracentrifuge (Beckman Coulter) spinning at 41,000 rpm for 22 h at 4 °C. Sucrose gradients were fractionated into 0.4 mL fractions and analyzed by native polyacrylamide gel electrophoresis. Fractions containing center positioned nucleosomes were concentrated and buffer exchanged into 0.5x TE pH 8 with a 30 kDa centrifugal filter. To verify purity, nucleosomes were analyzed by a native 5% acrylamide gel and 0.3x TBE (<xref ref-type="supplementary-material" rid="SD1">Supplementary Figure S1</xref>).</p></sec><sec id="S6"><title>Recombinant Gal4-DBD and Gal4-VP16 expression and purification</title><p id="P12">The Gal4 DNA binding domain from amino acid 1 to 147 (hereafter called Gal4-DBD) (<xref ref-type="bibr" rid="R48">48</xref>, <xref ref-type="bibr" rid="R53">53</xref>) and Gal4 DNA binding domain fused to the VP16 activator domain (hereafter called Gal4-VP16) (<xref ref-type="bibr" rid="R54">54</xref>) were expressed in Rosetta™ BL21 (DE3) pLysS cells. Cells were grown in 2xYT and induced at OD<sub>600</sub> of 0.5 with 1 mM IPTG and 100 mM zinc acetate. Cells were expressed for 3 h then spun at 4000 g for 15 minutes. The supernatant was removed, and cell pellets were frozen with liquid nitrogen.</p><p id="P13">Cells were thawed and resuspended in 30 mL of Gal4 buffer A (50 mM Tris-HCl pH 8, 200 mM NaCl, 10 mM imidazole, 10 mM BME, 20 μM zinc acetate, 1 mM DTT, and 1 mM PMSF) with leupeptin and pepstatin added at a final concentration of 20 <italic>μ</italic>g/ml. Resuspended cells were sonicated and spun at 23,000g for 15 minutes. Lysate containing the protein was collected. The lysate was added to a Ni-NTA column and washed with Gal4 buffer A. The protein was eluted with Gal4 buffer B (50 mM Tris-HCl pH 7.5, 200 mM NaCl, 200 mM imidazole, 20 μM zinc acetate, 1 mM DTT, 1 mM PMSF, and 0.2% TWEEN 20). Fractions were run on a 12% acrylamide SDS gel, pooled, and dialyzed into Gal4 buffer C with 200 mM NaCl (25 mM Tris-HCl pH 7.5, 200 mM NaCl, 20 μM zinc acetate, 1 mM DTT, and 1 mM PMSF). The protein was further purified after dialysis using cation exchange chromatography with a gradient from 200 mM to 600 mM NaCl using Gal4 buffer C with appropriate salt concentrations. Fractions containing the protein were pooled, concentrated, exchanged into Gal4 buffer D (10 mM HEPES pH 7.5, 200 mM NaCl, 10% glycerol, 20 μM zinc acetate, 1 mM DTT, and 1 mM PMSF), and then flash frozen for storage at -80 °C. The final yield was ~5 mg/L of culture grown. Purity was confirmed by SDS-PAGE (<xref ref-type="supplementary-material" rid="SD1">Supplementary Figure S2</xref>).</p></sec><sec id="S7"><title>ATAC and SAGA HAT module expression and purification</title><p id="P14">Recombinant ATAC and SAGA HAT modules were produced using the MultiBac system (<xref ref-type="bibr" rid="R55">55</xref>) as previously described (<xref ref-type="bibr" rid="R17">17</xref>). In short, a construct containing human KAT2A with a N-terminal histidine tag followed by a tobacco etch virus protease cleavage site, human TADA2A or TADA2B, mouse TADA3 and human SGF29 were integrated in the EMBacY bacmid via TN7 transposition (<xref ref-type="bibr" rid="R56">56</xref>). The resulting recombinant baculoviruses were then used to produce the corresponding HAT modules by infecting SF21 cells. Cells were harvested, flash-frozen in liquid nitrogen and stored at -80°C. For the purification, cell pellets of the respective HAT module were thawed and resuspended in HAT TALON buffer A (50 mM Trizma® base, 400 mM NaCl, 10 mM Imidazole, pH 8) supplemented with cOmplete™ EDTA-free protease inhibitor tablets (Roche) and Benzonase® nuclease. Resuspended cells were lysed using sonication and spun down at 40,000 x g for 45 minutes. The supernatant was additionally filtered through a folding filter and then incubated with HisPur™ Cobalt resin or loaded on a prepacked HiFliQ Cobalt-NTA FPLC column with a peristaltic pump. The protein was eluted via a step gradient of 7%, 30%, 50% and 100% HAT TALON buffer B (50 mM Trizma® base, 400 mM NaCl, 250 mM Imidazole, pH 8). The elutions were applied on an acrylamide SDS gel and fractions containing the complex were pooled accordingly. TCEP was added to a final concentration of 0.25 mM and the imidazole content diluted with HAT TALON buffer A where appropriate, to facilitate removal of the His-Tag by tobacco etch virus (TEV) protease cleavage of the His-Tag overnight. Samples were concentrated and loaded onto a Superdex 200 increase size exclusion chromatography (SEC) column equilibrated with HAT SEC buffer (25 mM Trizma® base, 400 mM NaCl, 0.25 mM TCEP, pH 8). Fractions were evaluated by SDS-PAGE (<xref ref-type="supplementary-material" rid="SD1">Supplementary Figure S3</xref>), pooled and concentrated. Aliquots were stored frozen in liquid nitrogen.</p></sec><sec id="S8"><title>Förster Resonance Energy Transfer efficiency measurements</title><p id="P15">For nucleosome-TF binding measurements, nucleosomes and TF were incubated with either the SAGA or ATAC HAT module and Ac-CoA in T75 buffer (10 mM Tris-HCl pH 8, 75 mM NaCl, 10% glycerol, and 0.25% Tween-20) in a 20 <italic>μ</italic>l volume at room temperature for at least 10 minutes and then analyzed using Horiba Scientific Fluoromax 4. Nucleosomes were at 1 nM in all experiments. For nucleosome-HAT module binding measurements, nucleosomes and either the ATAC or SAGA HAT module were incubated in T75 buffer in a 20 <italic>μ</italic>l volume at room temperature for at least 10 minutes as above. Fluorescence spectra were measured with Fluoromax 4 by exciting at 510 and 610 nm and measuring emission from 530 to 750 nm and 630 to 750 nm for donor and acceptor excitations, respectively. FRET efficiency was then calculated using the ratio<sub>A</sub> method (<xref ref-type="bibr" rid="R57">57</xref>). FRET efficiency values were normalized against the FRET efficiency value of nucleosomes in the absence of titrant. The titrations were carried out in triplicate. The average FRET efficiency and standard error was determined for each TF concentration. The S<sub>1/2</sub> and its standard error was then determined from a weighted fit to a non-cooperative binding isotherm using Prism 9 software.</p></sec><sec id="S9"><title>Fluorescence polarization measurements of HAT modules binding to nucleosomes</title><p id="P16">Fluorescent polarization measurements were carried out by mixing increasing amounts of either ATAC<sub>HAT</sub> or SAGA<sub>HAT</sub> with 5 nM NCP<sub>FA</sub> in 75 mM NaCl, 25 mM Tris-HCl pH 7.5, and 0.25% Tween20 in a 30 <italic>μ</italic>l reaction volume. 0.3 mM Ac-CoA was added to buffer for measurements taken with Ac-CoA. Samples were loaded and incubated in a Corning round bottom polystyrene plate. Polarization measurements were acquired using a Tecan infinite M1000Pro plate reader by exciting at 470 nm. Polarized emission was measured at 519 nm with 5 nm excitation and emission bandwidths. Fluorescence polarization was calculated from the emission polarized parallel and perpendicular to the polarized excitation light as previously described (<xref ref-type="bibr" rid="R58">58</xref>, <xref ref-type="bibr" rid="R59">59</xref>). The S<sub>1/2</sub> was determined by fitting the data to a non-cooperative binding isotherm. S<sub>1/2</sub> values were averaged over three separate experiments with error calculated as the standard error between the runs.</p></sec><sec id="S10"><title>Expression, Purification of Glutathione S-Transferase Fusion Proteins and HAT module Binding Assay</title><p id="P17">The expression and binding of Glutathione S-Transferase (GST) fusion proteins to glutathione Sepharose, and HAT binding assay (<xref ref-type="supplementary-material" rid="SD1">Supplementary Figure S4</xref>) was previously described (<xref ref-type="bibr" rid="R60">60</xref>). Briefly, <italic>Escherichia coli</italic>, DH5α were transformed with either pGEX-2T-GST or pGEX-2T-GST-VP16 vectors. Overnight cultures were diluted 1:100 in LB medium with ampicillin (100 mg/ml) and incubated at 37°C with shaking. After 1 h incubation, isopropyl-b-D-thiogalactopyranoside (IPTG) was added (final concentration 0.1 M) and the cultures were further incubated with shaking for 4 h. Cultures were pelleted by centrifugation at 5,000 g for 5 minutes at 4°C and pellets were resuspended in 1/10 volume of NETN buffer (20 mM Tris pH 8.0,100 mM NaCl, 1 mM EDTA, 0.5 % NP40), bacteria lysed by mild sonication and centrifuged at 10,000 g for 5 minutes at 4°C. Supernatants were loaded on Glutathione Sepharose 4B resin to immobilize either GST, or GST-VP16 fusion protein and incubated for 1h at 4°C. Following several washes of GST-, or GST-VP16-bound beads with NETN buffer; crude SF9 insect whole cell protein extract with no infection (as a negative control), SF9 cell extract expressing either the four ATAC<sub>HAT</sub>, or SAGA<sub>HAT</sub> module subunits, were loaded and incubated overnight at 4°C, then washed with five times NETN buffer containing either 75 mM or 150 mM NaCl. The resins were boiled in 1x Laemmli buffer and bound proteins resolved by SDS-polyacrylamide gel electrophoresis. Proteins were visualized by western blot analyses with the following antibodies (as indicated in the corresponding Figures): anti-GCN5 2GC2C11 mouse monoclonal antibody (mab) (<xref ref-type="bibr" rid="R61">61</xref>), anti-TADA3 #2678 rabbit polyclonal antibody (pAb) (<xref ref-type="bibr" rid="R25">25</xref>), anti-SGF29 #2461 pAb (<xref ref-type="bibr" rid="R25">25</xref>), anti-VP16 #5GV2 mAb (<xref ref-type="bibr" rid="R62">62</xref>).</p></sec><sec id="S11"><title>HAT assays and corresponding Western blot assays</title><p id="P18">Either the ATAC or SAGA HAT module were incubated with Gal4-VP16 or Gal4-DBD, along with 1 nM of nucleosomes in T75 buffer with 30 μM Ac-CoA for 30 minutes. Reaction was quenched with 6x SDS loading buffer and samples were incubated in 95°C for 5 minutes before loading onto a 16% SDS-PAGE gel. Gels were then transferred onto a membrane and H2A-Cy5 labeled nucleosomes were fluorescently imaged to control for loading. Membranes were incubated with anti-H3K9ac (abcam 4441) and anti-H4K5ac (abcam 51997) antibodies at 1:1000 concentrations at 4°C overnight. The membranes were then probed with horseradish peroxidase-conjugated secondary antibodies and developed with enhanced chemiluminescence western blotting substrate (Thermo Scientific). Blots were visualized with detection system. The protein bands were quantified using the densitometry analysis in ImageJ software (NIH, Washington, DC, USA). Statistical analysis was performed using GraphPad Prism software. Two-tailed, unpaired t-test with Welch’s correction was conducted using Prism 9 software. Error bars in figures represent standard error of the mean.</p></sec></sec><sec id="S12" sec-type="results"><title>Results</title><sec id="S13"><title>Human ATAC and SAGA HAT modules interact with unmodified nucleosomes independent of the acetyl-CoA cofactor</title><p id="P19">While ATAC and SAGA complexes are reported to interact with histone tails of nucleosomes (<xref ref-type="bibr" rid="R10">10</xref>), the mechanism of ATAC<sub>HAT</sub> and SAGA<sub>HAT</sub> interactions with nucleosomes remain elusive. To characterize human ATAC<sub>HAT</sub> and SAGA<sub>HAT</sub> interactions with nucleosomes, Fluorescence Anisotropy (FA) was performed using a fixed concentration of unmodified nucleosomes and increasing concentrations of either the ATAC<sub>HAT</sub> or SAGA<sub>HAT</sub>. Recombinant nucleosomes were prepared with a Widom 601 nucleosome positioning sequence (NPS) with a Gal4 binding site that starts at the eighth bp and extends 26 bp into the nucleosome (<xref ref-type="fig" rid="F1">Figure 1B</xref>). The Gal4 binding site is included for TF binding studies described below. On the side proximal to the Gal4 binding site, the nucleosome was labeled with a fluorescein fluorophore that is attached to a 30 bp DNA extension at the eighth bp outside of the nucleosome, while the side of the nucleosome that is distal to the Gal4 binding site contained a 75 bp DNA extension. As either the ATAC<sub>HAT</sub> or SAGA<sub>HAT</sub> was titrated, an increase in polarization of the fluorescein fluorophore was observed, indicative of binding (<xref ref-type="bibr" rid="R59">59</xref>). We report HAT module binding to nucleosomes as the S<sub>1/2</sub>, the concentration of the HAT module required for half of the nucleosomes to be bound. FA measurements were fit to a binding isotherm with the ATAC<sub>HAT</sub> binding with an S<sub>1/2</sub> of 23 ± 4 nM and reaching saturating conditions around 100 nM (<xref ref-type="fig" rid="F1">Figure 1D</xref>, <xref ref-type="supplementary-material" rid="SD1">Supplementary Table S1</xref>), while the SAGA<sub>HAT</sub> S<sub>1/2</sub> was 25.0 ± 0.3 nM, reaching saturating conditions around 100 nM (<xref ref-type="supplementary-material" rid="SD1">Supplementary Figure S5A</xref>). To determine the impact of acetylation catalysis on to the binding of the HAT modules to the nucleosome, we next added acetyl-CoA (Ac-CoA,) which is required for the acetylation activity of ATAC and SAGA (<xref ref-type="bibr" rid="R63">63</xref>). Titrations with Ac-CoA revealed that acetylation does not significantly impact the interaction of ATAC<sub>HAT</sub> and SAGA<sub>HAT</sub> modules with nucleosomes (<xref ref-type="fig" rid="F1">Figure 1D</xref>, <xref ref-type="supplementary-material" rid="SD1">Supplementary Figure S5A</xref>). Overall, these results indicate that ATAC<sub>HAT</sub> and SAGA<sub>HAT</sub> modules strongly bind unmodified nucleosomes independent of acetylation and TFs.</p></sec><sec id="S14"><title>Binding of ATAC and SAGA HAT modules to the nucleosome does not significantly alter the wrapping of DNA into the nucleosome</title><p id="P20">Histone H3 tails are primary targets for acetylation by ATAC and SAGA and extend away from the nucleosome, where the DNA exits. Therefore, we next investigated if the binding of ATAC<sub>HAT</sub> or SAGA<sub>HAT</sub> would change the amount of DNA wrapped into the nucleosome. To this end, we prepared nucleosomes labeled with both Cy3 and Cy5 fluorophores as we have done previously for other H3 tail binding domains (<xref ref-type="bibr" rid="R58">58</xref>, <xref ref-type="bibr" rid="R64">64</xref>). The DNA was labeled with Cy3 so it is located at the same locations as fluorescein, while the Cy5 was attached to histone H2AK119C (<xref ref-type="fig" rid="F1">Figure 1B-C</xref>). These labeling positions undergo efficient energy transfer when the nucleosome is fully wrapped, while the FRET efficiency reduces significantly as the nucleosome partially unwraps (<xref ref-type="bibr" rid="R65">65</xref>). We carried out titrations with ATAC<sub>HAT</sub> (<xref ref-type="fig" rid="F1">Figure 1E</xref>) and SAGA<sub>HAT</sub> (<xref ref-type="supplementary-material" rid="SD1">Supplementary Figure S5B</xref>) over the concentration range they bind nucleosomes. We found that the FRET reduction is minimal over the concentration range that they bind nucleosomes revealing that ATAC<sub>HAT</sub> and SAGA<sub>HAT</sub> binding does not directly impact nucleosome unwrapping.</p></sec><sec id="S15"><title>KAT2A, ATAC and SAGA HAT modules efficiently bind to the VP16 activator domain</title><p id="P21">Activators are known to interact with coactivator complexes. In the yeast SAGA complex, VP16 AD has been shown to specifically interact with the Tra1 subunit (<xref ref-type="bibr" rid="R66">66</xref>). Less is known about possible activator interactions with the mammalian ATAC<sub>HAT</sub> or SAGA<sub>HAT</sub> modules, nevertheless it has been shown that the human SAGA complex can bind to VP16 AD or to Myc (<xref ref-type="bibr" rid="R42">42</xref>, <xref ref-type="bibr" rid="R60">60</xref>). To investigate whether the ATAC<sub>HAT</sub> or SAGA<sub>HAT</sub> modules directly interact with the VP16 AD, we tested their binding abilities to the activation domain of VP16 when fused to GST (<xref ref-type="fig" rid="F2">Figure 2A</xref>). The GST-VP16 fusion protein was immobilized on glutathione-agarose resin in parallel with GST, as a negative control. ATAC<sub>HAT</sub> and SAGA<sub>HAT</sub> were able to bind to the GST-VP16 fusion protein, but not, or only very weakly, to GST alone (<xref ref-type="fig" rid="F2">Figure 2B-C</xref>). Moreover, we examined whether KAT2A alone could bind the VP16 AD. Similar to the results obtained with purified HAT modules, recombinantly purified KAT2A is able to bind directly to the VP16 AD (<xref ref-type="supplementary-material" rid="SD1">Supplementary Figure S4</xref>). These results indicate that the HAT modules of ATAC and SAGA can specifically interact with the VP16 AD and this interaction is possibly through a direct interaction between VP16 AD and KAT2A, which is the shared enzymatic subunit of ATAC and SAGA HAT complexes.</p></sec><sec id="S16"><title>Gal4-VP16 binds its target site within nucleosomes via the nucleosome site-exposure model</title><p id="P22">Having determined that ATAC<sub>HAT</sub> and SAGA<sub>HAT</sub> can efficiently bind the VP16 AD, we proceeded to investigate the binding of the well-established model transcription factor Gal4-VP16 within nucleosomes alone (<xref ref-type="bibr" rid="R54">54</xref>). The Gal4-VP16 fusion TF contains the first 147 amino acids of the Gal4 transcription factor (Gal4-DBD), which contains the DNA binding and dimerization domains, and is fused to the highly potent transcription VP-16 AD (<xref ref-type="fig" rid="F3">Figure 3A</xref>) (<xref ref-type="bibr" rid="R54">54</xref>). These measurements provide critical information for later measurements that include both Gal4-VP16 and either ATAC<sub>HAT</sub> or SAGA<sub>HAT</sub>.</p><p id="P23">To detect Gal4-VP16 binding to nucleosomes, we used the Cy3-Cy5 labeled nucleosomes that were used to detect if the HAT modules directly induce nucleosome unwrapping (<xref ref-type="fig" rid="F1">Figure 1A-B</xref>), which has been previously used to detect TF binding within nucleosomes (<xref ref-type="bibr" rid="R46">46</xref>, <xref ref-type="bibr" rid="R50">50</xref>, <xref ref-type="bibr" rid="R67">67</xref>). As mentioned above, the nucleosomes contained a 19 bp Gal4 binding site that starts at the eighth base pair and extends 26 base pairs into the Widom 601 NPS (<xref ref-type="fig" rid="F1">Figure 1B</xref>). This positions the Gal4 binding site within the nucleosome near, where the DNA exits the nucleosome and is reminiscent to positions of TF binding sites located <italic>in vivo</italic> (<xref ref-type="bibr" rid="R43">43</xref>–<xref ref-type="bibr" rid="R45">45</xref>). As Gal4-VP16 is titrated with these Cy3-Cy5 labeled nucleosomes, Gal4-VP16 binds to its site within the nucleosome via the nucleosome site exposure mechanism (<xref ref-type="fig" rid="F3">Figure 3B</xref>). This mechanism involves the nucleosome partially unwrapping, which transiently exposes the Gal4-VP16 target site. Gal4-VP16 then can bind to the site trapping the nucleosome in a partially unwrapped state. This results in a significant reduction in FRET efficiency.</p><p id="P24">We carried out FRET efficiency measurements of Gal4-VP16 titrations. As expected, the FRET efficiency is reduced as Gal4-VP16 traps the nucleosome in a partially unwrapped state (<xref ref-type="fig" rid="F3">Figure 3C</xref>). We fit the FRET efficiency measurements to a binding isotherm to determine the binding half saturation concentration, S<sub>1/2</sub>, which is interpreted as an apparent K<sub>D</sub>. We find that Gal4-VP16 binds to the target sequence within the nucleosome with an S<sub>1/2</sub> of 55 ± 2 nM (<xref ref-type="fig" rid="F3">Figure 3D</xref>). To control for the impact of the VP-16 AD we also carried out titrations with Gal4-DBD alone and determined an S<sub>1/2</sub> of 19 ± 1 nM. This shows that Gal4-VP16 is able to bind to its target site within nucleosomes. This binding appears to follow the site exposure model (<xref ref-type="bibr" rid="R4">4</xref>) even with the additional steric bulk of the VP16 activator, although with a 3-fold higher apparent K<sub>D</sub>.</p></sec><sec id="S17"><title>The transcription activator Gal4-VP16 significantly enhances the acetylation of nucleosomes by the HAT modules of ATAC and SAGA</title><p id="P25">Having determined that (i) the ATAC<sub>HAT</sub> and SAGA<sub>HAT</sub> interact directly with nucleosomes, (ii) the VP16 activator domain directly interacts with ATAC<sub>HAT</sub> and SAGA<sub>HAT</sub>, and (iii) Gal4-VP16 binds efficiently within nucleosomes via the site exposure model, we decided to investigate the influence of Gal4-VP16 on the ability for ATAC<sub>HAT</sub> and SAGA<sub>HAT</sub> to acetylate nucleosomes within histone H3 and H4 tails. Nucleosomes were incubated for 30 minutes with an increasing concentration of either ATAC<sub>HAT</sub> or SAGA<sub>HAT</sub>, Ac-CoA, and either with or without Gal4-VP16. The HAT module concentrations were increased over the concentration at which they bind nucleosomes (<xref ref-type="fig" rid="F1">Figure 1</xref>). A Gal4-VP16 concentration of 160 nM was used to ensure saturated binding since it is approximately 2.5-fold higher than the S<sub>1/2</sub> measured by the above FRET measurements (<xref ref-type="fig" rid="F3">Figure 3D</xref>). Western blot assays were used to quantify the acetylation of the H3 tail at lysine 9 (H3K9) and the H4 tail at lysine 5 (H4K5) with and without Gal4-VP16 (<xref ref-type="fig" rid="F4">Figure 4</xref>). To control for nucleosome loading we relied on Cy5 fluorescence, which is attached to H2A at K119C.</p><p id="P26">We find that Gal4-VP16 enhances acetylation of both H3K9 and H4K5 by ATAC<sub>HAT</sub> (<xref ref-type="fig" rid="F4">Figure 4A-C</xref>). At sub-saturating concentrations of 70 nM ATAC<sub>HAT</sub>, Gal4-VP16 induced a 5-fold and 6-fold increase in the acetylation of H3K9 and a H4K5, respectively (<xref ref-type="fig" rid="F4">Figure 4B-C</xref>, <xref ref-type="supplementary-material" rid="SD1">Supplementary Table S2</xref>). In contrast, the impact of Gal4-VP16 on acetylation by SAGA<sub>HAT</sub> was less dramatic. At the sub-saturating concentration of 20 nM SAGA<sub>HAT</sub>, Gal4-VP16 increased acetylation activity at H3K9 by 3-fold (<xref ref-type="fig" rid="F4">Figure 4E</xref>), while at the H4K5 location, Gal4-VP16 increased acetylation activity modestly. At 20 nM of SAGA<sub>HAT</sub>, Gal4-VP16 did not induce a statistically significant increase in acetylation of H4K5, while a statistically significant change in acetylation of H4K5 (2.2-fold) with 70 nM SAGA<sub>HAT</sub> and Gal4-VP16 was observed.</p><p id="P27">These observed differences in acetylation by ATAC<sub>HAT</sub> and SAGA<sub>HAT</sub> are consistent with <italic>in vivo</italic> studies, where SAGA targets H3 at K9 and K14 (<xref ref-type="bibr" rid="R17">17</xref>, <xref ref-type="bibr" rid="R21">21</xref>, <xref ref-type="bibr" rid="R22">22</xref>), while ATAC appears to acetylate both histone H3 and H4 (<xref ref-type="bibr" rid="R16">16</xref>, <xref ref-type="bibr" rid="R23">23</xref>–<xref ref-type="bibr" rid="R27">27</xref>). In addition, the difference in the impact of Gal4-VP16 on acetylation by ATAC<sub>HAT</sub> could in part be due to the lower starting activity of ATAC<sub>HAT</sub> as compared to SAGA<sub>HAT</sub>, allowing Gal4-VP16 to have a larger impact on ATAC<sub>HAT</sub> acetylation activity. Overall, these results indicate that Gal4-VP16, which directly interacts with both HAT modules and nucleosomes that contain the Gal4 binding site, facilitates acetylation of both the H3 and H4 tails by both HAT modules, although Gal4-VP16 has a larger impact on ATAC<sub>HAT</sub> targeted acetylation.</p></sec><sec id="S18"><title>Trapping the nucleosome in a partially unwrapped state enhances the ATAC HAT module acetylation activity but suppresses the SAGA HAT module acetylation activity</title><p id="P28">The increase in HAT module acetylation activity by Gal4-VP16 could occur by two non-mutually exclusive mechanisms. The first mechanism is that the direct interaction of the VP16 AD helps stabilize the HAT module binding to the nucleosome, which in turn enhances the acetylation activity. The second mechanism is that Gal4-VP16 traps the nucleosome in a partially unwrapped state, increasing the exposure of the H3 and H4 tails for HAT module binding and acetylation. To determine the impact of nucleosome unwrapping alone, we carried out the above-described acetylation activity measurements with Gal4-DBD alone, which does not contain the VP16 AD. Gal4-DBD reduces the FRET efficiency as it binds its target site within the nucleosome, demonstrating that it traps the nucleosome in a partially unwrapped state similarly to Gal4-VP16 (<xref ref-type="fig" rid="F3">Figure 3</xref>). This allowed the determination of the impact of the DBD of a TF trapping the nucleosome in an unwrapped state on HAT module acetylation activity without the confounding impact of interactions with an activator domain.</p><p id="P29">As with Gal4-VP16, nucleosomes were incubated for 30 minutes with an increasing concentration of either ATAC<sub>HAT</sub> or SAGA<sub>HAT</sub>, with Ac-CoA, and either with or without 70 nM Gal4-DBD, which ensures saturating binding of nucleosomes by Gal4-DBD (<xref ref-type="fig" rid="F3">Figure 3</xref>). Western blot assays were again used to quantify the acetylation at H3K9 and H4K5. We observe minimal acetylation activity at H3K9 below 70 nM of ATAC<sub>HAT</sub> and 20 nM SAGA<sub>HAT</sub> (<xref ref-type="supplementary-material" rid="SD1">Supplementary Figure S6</xref>). Interestingly at 70 nM of ATAC<sub>HAT</sub>, which is near the apparent K<sub>D</sub>, the acetylation activity of H3K9 is increased 4-fold by Gal4-DBD. At the saturating concentration of 200 nM ATAC<sub>HAT</sub>, Gal4-DBD no longer influences the acetylation activity at H3K9 (<xref ref-type="supplementary-material" rid="SD1">Supplementary Figure S6</xref>, <xref ref-type="supplementary-material" rid="SD1">Supplementary Table S3</xref>). In contrast, we find that Gal4-DBD does not induce a statistically significant change in the acetylation activity of ATAC<sub>HAT</sub> at H4K5. For SAGA<sub>HAT</sub>, we found that Gal4-DBD did not enhance the acetylation activity of SAGA<sub>HAT</sub> at either H3K9 or H4K5 (<xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 6</xref>, <xref ref-type="supplementary-material" rid="SD1">Supplementary Table S3</xref>). Instead, the acetylation activity was reduced by about a factor of 2 at H3K9 with 70 nM SAGA<sub>HAT</sub>, while the change in acetylation activity at H4K5 was not statistically significant at any SAGA<sub>HAT</sub> concentration.</p><p id="P30">These results are consistent with the structure of the nucleosome. The H3 tail extends out from the nucleosome where the DNA exits the nucleosome, which positions the H3 tail such that a partial nucleosome unwrapping could impact its accessibility. In contrast, the H4 tails extends out from the face of the histone octamer, which is at a position where partial nucleosome unwrapping is not likely to enhance H4 tail accessibility. Interestingly, these findings also suggest that trapping the nucleosome in a partially unwrapped state with Gal4-DBD provides ATAC<sub>HAT</sub> additional access to the H3 tail to acetylate H3K9 but suppresses H3 tail access to SAGA<sub>HAT</sub>. This points to a possible mechanism where a TF can differentially target histone H3 tail acetylation by these two HAT modules.</p></sec><sec id="S19"><title>ATAC and SAGA HAT modules influence transcription factor accessibility in an acetylation-independent manner</title><p id="P31">Co-activator complexes are reported to be recruited to promoter regions by transcription factors to aid Pol II transcription initiation (<xref ref-type="bibr" rid="R68">68</xref>). However, the mechanisms by which coactivator complexes and transcription factors function together is still not fully understood. In the acetylation assays, we showed that the addition of Gal4-VP16 can significantly enhance the acetylation function of the studied HAT modules. This finding raised the question: do the HAT modules in turn influence the accessibility of Gal4-VP16 to the nucleosome? To investigate how ATAC<sub>HAT</sub> and SAGA<sub>HAT</sub> function with a TF to target nucleosomes, we used ensemble FRET efficiency measurements to quantify Gal4-VP16 binding within partially unwrapped nucleosomes in the presence or absence of either the ATAC<sub>HAT</sub> or SAGA<sub>HAT</sub> (<xref ref-type="fig" rid="F5">Figure 5A</xref>, <xref ref-type="fig" rid="F5">D</xref>). By comparing the Gal4-VP16 S<sub>1/2</sub> for binding to nucleosomes with and without the HAT modules, we determined the impact of the HAT modules on the site accessibility for Gal4-VP16 occupancy at its site within a partially unwrapped nucleosome.</p><p id="P32">We used HAT module concentrations of 200 nM and 150 nM for ATAC<sub>HAT</sub> or SAGA<sub>HAT</sub>, respectively, to ensure that the HAT modules were at concentrations that efficiently bind nucleosomes (<xref ref-type="fig" rid="F1">Figure 1D</xref>). We carried out these measurements without Ac-CoA to eliminate the impact of histone acetylation on Gal4-VP16 binding. In the presence of ATAC<sub>HAT</sub>, the binding affinity of Gal4-VP16 increased by 10-fold where the S<sub>1/2</sub> lowered from 55 ± 2 nM to 5.3 ± 0.7 nM (<xref ref-type="fig" rid="F5">Figure 5B-C</xref>, <xref ref-type="supplementary-material" rid="SD1">Supplementary Table S4</xref>). Likewise, the addition of SAGA<sub>HAT</sub> increased the ability of Gal4-VP16 to bind by 8-fold where the S<sub>1/2</sub> of Gal4-VP16 lowered to 7 ± 1 nM (<xref ref-type="fig" rid="F5">Figure 5E-F</xref>, <xref ref-type="supplementary-material" rid="SD1">Supplementary Table S4</xref>). We then repeated these measurements with 30 μM Acetyl-CoA to determine how histone acetylation influences the impact of the HAT modules on Gal4-VP16 binding. We found that the addition of Ac-CoA did not statistically impact in the binding affinity of Gal4-VP16 (<xref ref-type="fig" rid="F5">Figure 5C</xref>, <xref ref-type="fig" rid="F5">F</xref>), which implies that the order of magnitude increases in Gal4-VP16 binding within the nucleosome by ATAC<sub>HAT</sub> and SAGA<sub>HAT</sub>, but this increase is acetylation independent.</p><p id="P33">Since VP16 AD directly interacts with both HAT modules, we investigated if the VP16 AD is required for the acetylation independent increase in Gal4-VP16 binding by determining if the HAT modules facilitate Gal4-DBD binding and by how much. We carried out Gal4-DBD titrations with and without ATAC<sub>HAT</sub> or SAGA<sub>HAT</sub> to determine the change in the S<sub>1/2</sub> of Gal4-DBD binding (<xref ref-type="supplementary-material" rid="SD1">Supplementary Figure S7</xref>, <xref ref-type="supplementary-material" rid="SD1">Supplementary Table S4</xref>). We found that ATAC<sub>HAT</sub> increased Gal4-DBD binding by about 2.5-fold, where the S<sub>1/2</sub> decreases from 19 ± 1 nM to 7.6 ± 0.8 nM, while SAGA<sub>HAT</sub> increases Gal4-DBD binding by about 4-fold where the S<sub>1/2</sub> decreased to 4.9 ± 0.3 nM. We also investigated the impact of Ac-CoA and found that this increase in Gal4-DBD binding was not significantly altered by the acetylation activity of either HAT module, implying that the enhanced binding of Gal4-DBD by both HAT modules is acetylation independent.</p><p id="P34">In combination, these results indicate that the VP16 AD is important for the order of magnitude increase of Gal4-VP16 binding induced by either ATAC<sub>HAT</sub> or SAGA<sub>HAT</sub>. This is likely due to direct interactions between VP16 and the HAT modules. However, the more modest increase binding of Gal4 DBD alone indicates that while the HAT modules do not directly induce nucleosome unwrapping (<xref ref-type="fig" rid="F1">Figure 1E</xref>, <xref ref-type="supplementary-material" rid="SD1">Supplementary Figure S5B</xref>), they can help stabilize Gal4 binding even without directly interacting with an activator domain, perhaps by preventing rewrapping. Overall, these findings indicate that not only do transcription activating TFs, such as Gal4-VP16, enhance ATAC<sub>HAT</sub> and SAGA<sub>HAT</sub> acetylation, but these HAT modules also facilitate TF binding independent of the acetylation activity.</p></sec></sec><sec id="S20" sec-type="discussion"><title>Discussion</title><p id="P35">This study provides quantitative and mechanistic insight into how the HAT modules of two important co-activators, ATAC and SAGA, function with a transcription activating TF to target and open chromatin. Our results reveal that both ATAC<sub>HAT</sub> and SAGA<sub>HAT</sub> have two distinct yet synergistic functions: (i) coordinate with TFs to acetylate histones to open chromatin and (ii) target the same TFs to its binding site within the nucleosome. These observations also provide insight into how both the ATAC and SAGA full complexes function with a TF. KAT2A and other SAGA subunits have been reported to interact with transcription activating TFs (<xref ref-type="bibr" rid="R36">36</xref>), while ATAC subunit(s) that directly interacts with TFs has yet to be characterized. Interestingly, our <italic>in vitro</italic> binding experiments suggest that KAT2A in both ATAC<sub>HAT</sub> and SAGA<sub>HAT</sub> is likely to contribute to TF binding, and consequently to the recruitment of these HAT modules, and/or their holo complexes, to activate genes. In addition, the SAGA holo complex contains the TRRAP subunit that also interacts with TFs (<xref ref-type="bibr" rid="R38">38</xref>). In a recent screen test of 109 human TFs’ interactions with other proteins by proximity-dependent biotinylation (BioID) and affinity purification mass spectrometry (AP-MS) measurements, the authors described that the endogenous ATAC complex interacts with E2F1; ELF1, HNF4a, KLF3, KLF12, MYC; PPARγ, TYY1 TFs, while endogenous SAGA complex was shown to interact with KLF6, MYC, and MYOD TFs (<xref ref-type="bibr" rid="R69">69</xref>). Our results indicate that the ATAC and SAGA HAT modules may contribute to these TF interactions, which could help target the ATAC and/or SAGA holo complexes to promoters and enhancers. In addition, these HAT modules could also function outside of the endogenous ATAC and SAGA holo complexes (<xref ref-type="bibr" rid="R36">36</xref>, <xref ref-type="bibr" rid="R37">37</xref>). Thus, it is conceivable that TFs can directly target the HAT modules, free or incorporated in their respective holo complexes, to TF target sites allowing the ATAC<sub>HAT</sub> and SAGA<sub>HAT</sub> modules or their holo complexes to function as transcription co-activators.</p><p id="P36">Our studies of the impact of Gal4-VP16 vs. Gal4-DBD on the acetylation activities of ATAC<sub>HAT</sub> and SAGA<sub>HAT</sub> allowed us to decouple the impact of the VP16 activator direct interaction with the HAT modules and the impact of the TF trapping the nucleosome in a partially unwrapped state. The combined results of Gal4-VP16 and Gal4-DBD indicate that a TF with an activator domain that directly interacts with the HAT module enhances ATAC<sub>HAT</sub> acetylation of the H3 tail by 2 mechanisms: (i) it facilitates recruitment of ATAC<sub>HAT</sub> module through direct interactions with the activator domain, and (ii) it increases ATAC<sub>HAT</sub> accessibility to the histone tail through partial nucleosome unwrapping. In contrast, only the first mechanism appears to be important for ATAC<sub>HAT</sub> acetylation of the H4 tail, which as mentioned above is consistent with the location of the H4 tail within the nucleosome. For SAGA<sub>HAT</sub>, trapping the nucleosome in a partially unwrapped state does not impact its acetylation activity, implying that only the first mechanism has a significant impact on SAGA<sub>HAT</sub> acetylation activity of both the H3 and H4 tails. These results highlight differences between the two HAT modules, which could be important in how ATAC<sub>HAT</sub> and SAGA<sub>HAT</sub> target distinct chromatin locations.</p><p id="P37">The new function of ATAC<sub>HAT</sub> and SAGA<sub>HAT</sub> modules identified in this study by <italic>in vitro</italic> experiments, where they help target a TF to its recognition site within a nucleosome, is highly synergistic with their well-established function to acetylate histones. By helping the TF target their binding sites within nucleosomes, ATAC<sub>HAT</sub> and SAGA<sub>HAT</sub> enhance the targeting for their own HAT activity. This targeting could happen through three non-exclusive models (<xref ref-type="fig" rid="F6">Figure 6</xref>) where either the TF and nucleosome bind first (Model 1), the TF and the HAT module bind first (Model 2), or the HAT module and the nucleosome bind first (Model 3). Since we found that Gal4-VP16, HAT modules, and nucleosomes all interact strongly with each other, it is possible that all three pair wise interactions are possible pathways to the nucleosome being bound by both Gal4-VP16 and a HAT module. Our current studies do not differentiate between these pathways. However, a previous study reported that suppression of Gal4-DBD occupancy at its site within the nucleosome is dominated by nucleosome accelerated dissociation (<xref ref-type="bibr" rid="R70">70</xref>). This suggests that when the nucleosome is bound by Gal4-VP16 and the HAT module, both could have a slower dissociation rate, which would result in increased dissociation equilibrium constant irrespective of the dominate model(s) in <xref ref-type="fig" rid="F6">Figure 6</xref>. Future studies are needed to investigate the key states that allow both HAT modules to increase Gal4 binding by an order of magnitude.</p><p id="P38">Interestingly, recent molecular and genetic studies revealed that many histone-modifying enzymes have functions independent of their HAT, or methyltransferase activities. Many of the histone modifications deposited by these enzymes, previously considered to be crucial for transcriptional activation, have been demonstrated to function for gene expression independent of their catalytic activities (<xref ref-type="bibr" rid="R71">71</xref>–<xref ref-type="bibr" rid="R73">73</xref>). Our discovery of the new HAT- independent function of the ATAC and SAGA HAT modules in targeting TFs to their recognition sites within chromatin in a HAT-independent manner, suggests that the newly discovered function of these chromatin-modifying complexes may be even more important than their given enzymatic activities. Future experiments will be required to verify whether the HAT-independent targeting role of these complexes also operates in living organisms.</p></sec><sec sec-type="supplementary-material" id="SM"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SD1"><label>Supplementary Figures</label><media xlink:href="EMS190329-supplement-Supplementary_Figures.pdf" mimetype="application" mime-subtype="pdf" id="d32aAdEbB" position="anchor"/></supplementary-material></sec></body><back><ack id="S21"><title>Acknowledgements</title><p>We thank the members of the Poirier, Tora, and Berger labs for helpful discussions and comments. We are grateful the Parthun lab and the Musier-Forsyth labs for help with the Western Blots. This work was supported by the National Institutes of Health (R35 GM139564 to M.G.P. and L.T., and R01 GM131626), and the Agence Nationale de la Recherche (ANR) (ANR-19-CE11-0003-02 to L.T., ANR-20-CE12-0017-03 to L.T., ANR-PRCI-19-CE12-0029-01 to L.T., ANR-22-CE11-0013-01_ACT; to L.T.). As part of the ITI 2021-2028 program of the University of Strasbourg, this work was also supported by IdEx Unistra (ANR-10-IDEX-0002), and by SFRI-STRAT’US project (ANR 20-SFRI-0012) and EUR IMCBio (ANR-17-EURE-0023) under the framework of the French Investments for the Future Program. IB is supported by the Wellcome Trust (106115/Z/14/Z).</p></ack><sec id="S22" sec-type="data-availability"><title>Data Availability</title><p id="P39">The experimental data sets are either included in this manuscript, the supplemental information, or are available from the authors upon request.</p></sec><fn-group><fn id="FN1" fn-type="con"><p id="P40"><bold>Contributions</bold></p><p id="P41">K.Chesnutt, M.G.P., and L.T. conceived and designed the research. K.Chesnutt carried out the FA, Western blot, and FRET experiments. K.Chesnutt and K.Cox prepared the nucleosome samples. G.Y. carried out the pull-down experiments. C.T. and G.G. prepared the ATAC and SAGA HAT modules. M.G.P. and L.T. supervised the study. K.Chesnutt, M.G.P. and L.T. wrote the first draft. All authors edited and finalized the manuscript.</p></fn></fn-group><ref-list><ref id="R1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luger</surname><given-names>K</given-names></name><name><surname>Mäder</surname><given-names>AW</given-names></name><name><surname>Richmond</surname><given-names>RK</given-names></name><name><surname>Sargent</surname><given-names>DF</given-names></name><name><surname>Richmond</surname><given-names>TJ</given-names></name></person-group><article-title>Crystal structure of the nucleosome core particle at 2.8 Å resolution</article-title><source>Nature</source><year>1997</year><volume>389</volume><fpage>251</fpage><lpage>260</lpage><pub-id pub-id-type="pmid">9305837</pub-id></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richmond</surname><given-names>TJ</given-names></name><name><surname>Davey</surname><given-names>CA</given-names></name></person-group><article-title>The structure of DNA in the nucleosome core</article-title><source>Nature</source><year>2003</year><volume>423</volume><fpage>145</fpage><lpage>150</lpage><pub-id pub-id-type="pmid">12736678</pub-id></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>S</given-names></name><name><surname>Davey</surname><given-names>CA</given-names></name></person-group><article-title>Nucleosome structural studies</article-title><source>Curr Opin Struct Biol</source><year>2011</year><volume>21</volume><fpage>128</fpage><lpage>136</lpage><pub-id pub-id-type="pmcid">PMC3052702</pub-id><pub-id pub-id-type="pmid">21176878</pub-id><pub-id pub-id-type="doi">10.1016/j.sbi.2010.11.006</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Polach</surname><given-names>KJ</given-names></name><name><surname>Widom</surname><given-names>J</given-names></name></person-group><article-title>Mechanism of Protein Access to Specific DNA Sequences in Chromatin: A Dynamic Equilibrium Model for Gene Regulation</article-title><source>J Mol Biol</source><year>1995</year><volume>254</volume><fpage>130</fpage><lpage>149</lpage><pub-id pub-id-type="pmid">7490738</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>PJJ</given-names></name><name><surname>Rhodes</surname><given-names>D</given-names></name></person-group><article-title>Structure of the ‘30 nm’ chromatin fibre: a key role for the linker histone</article-title><source>Curr Opin Struct Biol</source><year>2006</year><volume>16</volume><fpage>336</fpage><lpage>343</lpage><pub-id pub-id-type="pmid">16714106</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lowary</surname><given-names>PT</given-names></name><name><surname>Widom</surname><given-names>J</given-names></name></person-group><article-title>New DNA sequence rules for high affinity binding to histone octamer and sequence-directed nucleosome positioning</article-title><source>J Mol Biol</source><year>1998</year><volume>276</volume><fpage>19</fpage><lpage>42</lpage><pub-id pub-id-type="pmid">9514715</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bannister</surname><given-names>AJ</given-names></name><name><surname>Kouzarides</surname><given-names>T</given-names></name></person-group><article-title>Regulation of chromatin by histone modifications</article-title><source>Cell Res</source><year>2011</year><volume>21</volume><fpage>381</fpage><lpage>395</lpage><pub-id pub-id-type="pmcid">PMC3193420</pub-id><pub-id pub-id-type="pmid">21321607</pub-id><pub-id pub-id-type="doi">10.1038/cr.2011.22</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yun</surname><given-names>M</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Workman</surname><given-names>JL</given-names></name><name><surname>Li</surname><given-names>B</given-names></name></person-group><article-title>Readers of histone modifications</article-title><source>Cell Res</source><year>2011</year><volume>21</volume><fpage>564</fpage><lpage>578</lpage><pub-id pub-id-type="pmcid">PMC3131977</pub-id><pub-id pub-id-type="pmid">21423274</pub-id><pub-id pub-id-type="doi">10.1038/cr.2011.42</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Helmlinger</surname><given-names>D</given-names></name><name><surname>Tora</surname><given-names>L</given-names></name></person-group><article-title>Sharing the SAGA</article-title><source>Trends Biochem Sci</source><year>2017</year><volume>42</volume><fpage>850</fpage><lpage>861</lpage><pub-id pub-id-type="pmcid">PMC5660625</pub-id><pub-id pub-id-type="pmid">28964624</pub-id><pub-id pub-id-type="doi">10.1016/j.tibs.2017.09.001</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Helmlinger</surname><given-names>D</given-names></name><name><surname>Papai</surname><given-names>G</given-names></name><name><surname>Devys</surname><given-names>D</given-names></name><name><surname>Tora</surname><given-names>L</given-names></name></person-group><article-title>What do the structures of GCN5-containing complexes teach us about their function?</article-title><source>Biochim Biophys Acta Gene Regul Mech</source><year>2021</year><volume>1864</volume><elocation-id>194614</elocation-id><pub-id pub-id-type="pmid">32739556</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Helmlinger</surname><given-names>D</given-names></name><name><surname>Tora</surname><given-names>L</given-names></name></person-group><article-title>Sharing the SAGA</article-title><source>Trends Biochem Sci</source><year>2017</year><volume>42</volume><fpage>850</fpage><lpage>861</lpage></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spedale</surname><given-names>G</given-names></name><name><surname>Timmers</surname><given-names>HTM</given-names></name><name><surname>Pijnappel</surname><given-names>WWMP</given-names></name></person-group><article-title>ATAC-king the complexity of SAGA during evolution</article-title><source>Genes Dev</source><year>2012</year><volume>26</volume><fpage>527</fpage><lpage>541</lpage><pub-id pub-id-type="pmcid">PMC3315114</pub-id><pub-id pub-id-type="pmid">22426530</pub-id><pub-id pub-id-type="doi">10.1101/gad.184705.111</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herbst</surname><given-names>DA</given-names></name><name><surname>Esbin</surname><given-names>MN</given-names></name><name><surname>Louder</surname><given-names>RK</given-names></name><name><surname>Dugast-Darzacq</surname><given-names>C</given-names></name><name><surname>Dailey</surname><given-names>GM</given-names></name><name><surname>Fang</surname><given-names>Q</given-names></name><name><surname>Darzacq</surname><given-names>X</given-names></name><name><surname>Tjian</surname><given-names>R</given-names></name><name><surname>Nogales</surname><given-names>E</given-names></name></person-group><article-title>Structure of the human SAGA coactivator complex</article-title><source>Nat Struct Mol Biol</source><year>2021</year><volume>28</volume><fpage>989</fpage><lpage>996</lpage><pub-id pub-id-type="pmcid">PMC8660637</pub-id><pub-id pub-id-type="pmid">34811519</pub-id><pub-id pub-id-type="doi">10.1038/s41594-021-00682-7</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>KK</given-names></name><name><surname>Sardiu</surname><given-names>ME</given-names></name><name><surname>Swanson</surname><given-names>SK</given-names></name><name><surname>Gilmore</surname><given-names>JM</given-names></name><name><surname>Torok</surname><given-names>M</given-names></name><name><surname>Grant</surname><given-names>PA</given-names></name><name><surname>Florens</surname><given-names>L</given-names></name><name><surname>Workman</surname><given-names>JL</given-names></name><name><surname>Washburn</surname><given-names>MP</given-names></name></person-group><article-title>Combinatorial depletion analysis to assemble the network architecture of the SAGA and ADA chromatin remodeling complexes</article-title><source>Mol Syst Biol</source><year>2011</year><volume>7</volume><fpage>503</fpage><pub-id pub-id-type="pmcid">PMC3159981</pub-id><pub-id pub-id-type="pmid">21734642</pub-id><pub-id pub-id-type="doi">10.1038/msb.2011.40</pub-id></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papai</surname><given-names>G</given-names></name><name><surname>Frechard</surname><given-names>A</given-names></name><name><surname>Kolesnikova</surname><given-names>O</given-names></name><name><surname>Crucifix</surname><given-names>C</given-names></name><name><surname>Schultz</surname><given-names>P</given-names></name><name><surname>Ben-Shem</surname><given-names>A</given-names></name></person-group><article-title>Structure of SAGA and mechanism of TBP deposition on gene promoters</article-title><source>Nature</source><year>2020</year><volume>577</volume><fpage>711</fpage><lpage>716</lpage><pub-id pub-id-type="pmid">31969704</pub-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Dienemann</surname><given-names>C</given-names></name><name><surname>Stützer</surname><given-names>A</given-names></name><name><surname>Urlaub</surname><given-names>H</given-names></name><name><surname>Cheung</surname><given-names>ACM</given-names></name><name><surname>Cramer</surname><given-names>P</given-names></name></person-group><article-title>Structure of the transcription coactivator SAGA</article-title><source>Nature</source><year>2020</year><volume>577</volume><fpage>717</fpage><lpage>720</lpage><pub-id pub-id-type="pmcid">PMC6994259</pub-id><pub-id pub-id-type="pmid">31969703</pub-id><pub-id pub-id-type="doi">10.1038/s41586-020-1933-5</pub-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riss</surname><given-names>A</given-names></name><name><surname>Scheer</surname><given-names>E</given-names></name><name><surname>Joint</surname><given-names>M</given-names></name><name><surname>Trowitzsch</surname><given-names>S</given-names></name><name><surname>Berger</surname><given-names>I</given-names></name><name><surname>Tora</surname><given-names>L</given-names></name></person-group><article-title>Subunits of ADA-two-A-containing (ATAC) or Spt-Ada-Gcn5-acetyltrasferase (SAGA) Coactivator Complexes Enhance the Acetyltransferase Activity of GCN5</article-title><source>J Biol Chem</source><year>2015</year><volume>290</volume><fpage>28997</fpage><lpage>29009</lpage><pub-id pub-id-type="pmcid">PMC4661412</pub-id><pub-id pub-id-type="pmid">26468280</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M115.668533</pub-id></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yayli</surname><given-names>G</given-names></name><name><surname>Bernardini</surname><given-names>A</given-names></name><name><surname>Mendoza Sanchez</surname><given-names>PK</given-names></name><name><surname>Scheer</surname><given-names>E</given-names></name><name><surname>Damilot</surname><given-names>M</given-names></name><name><surname>Essabri</surname><given-names>K</given-names></name><name><surname>Morlet</surname><given-names>B</given-names></name><name><surname>Negroni</surname><given-names>L</given-names></name><name><surname>Vincent</surname><given-names>SD</given-names></name><name><surname>Timmers</surname><given-names>HTM</given-names></name><etal/></person-group><article-title>ATAC and SAGA co-activator complexes utilize co-translational assembly, but their cellular localization properties and functions are distinct</article-title><source>Cell Rep</source><year>2023</year><volume>42</volume><elocation-id>113099</elocation-id><pub-id pub-id-type="pmcid">PMC10591836</pub-id><pub-id pub-id-type="pmid">37682711</pub-id><pub-id pub-id-type="doi">10.1016/j.celrep.2023.113099</pub-id></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kusch</surname><given-names>T</given-names></name><name><surname>Guelman</surname><given-names>S</given-names></name><name><surname>Abmayr</surname><given-names>SM</given-names></name><name><surname>Workman</surname><given-names>JL</given-names></name></person-group><article-title>Two Drosophila Ada2 homologues function in different multiprotein complexes</article-title><source>Mol Cell Biol</source><year>2003</year><volume>23</volume><fpage>3305</fpage><lpage>3319</lpage><pub-id pub-id-type="pmcid">PMC153191</pub-id><pub-id pub-id-type="pmid">12697829</pub-id><pub-id pub-id-type="doi">10.1128/MCB.23.9.3305-3319.2003</pub-id></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muratoglu</surname><given-names>S</given-names></name><name><surname>Georgieva</surname><given-names>S</given-names></name><name><surname>Pápai</surname><given-names>G</given-names></name><name><surname>Scheer</surname><given-names>E</given-names></name><name><surname>Enünlü</surname><given-names>I</given-names></name><name><surname>Komonyi</surname><given-names>O</given-names></name><name><surname>Cserpán</surname><given-names>I</given-names></name><name><surname>Lebedeva</surname><given-names>L</given-names></name><name><surname>Nabirochkina</surname><given-names>E</given-names></name><name><surname>Udvardy</surname><given-names>A</given-names></name><etal/></person-group><article-title>Two different Drosophila ADA2 homologues are present in distinct GCN5 histone acetyltransferase-containing complexes</article-title><source>Mol Cell Biol</source><year>2003</year><volume>23</volume><fpage>306</fpage><lpage>321</lpage><pub-id pub-id-type="pmcid">PMC140672</pub-id><pub-id pub-id-type="pmid">12482983</pub-id><pub-id pub-id-type="doi">10.1128/MCB.23.1.306-321.2003</pub-id></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonnet</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>C-Y</given-names></name><name><surname>Baptista</surname><given-names>T</given-names></name><name><surname>Vincent</surname><given-names>SD</given-names></name><name><surname>Hsiao</surname><given-names>W-C</given-names></name><name><surname>Stierle</surname><given-names>M</given-names></name><name><surname>Kao</surname><given-names>C-F</given-names></name><name><surname>Tora</surname><given-names>L</given-names></name><name><surname>Devys</surname><given-names>D</given-names></name></person-group><article-title>The SAGA coactivator complex acts on the whole transcribed genome and is required for RNA polymerase II transcription</article-title><source>Genes Dev</source><year>2014</year><volume>28</volume><fpage>1999</fpage><lpage>2012</lpage><pub-id pub-id-type="pmcid">PMC4173158</pub-id><pub-id pub-id-type="pmid">25228644</pub-id><pub-id pub-id-type="doi">10.1101/gad.250225.114</pub-id></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feller</surname><given-names>C</given-names></name><name><surname>Forné</surname><given-names>I</given-names></name><name><surname>Imhof</surname><given-names>A</given-names></name><name><surname>Becker</surname><given-names>PB</given-names></name></person-group><article-title>Global and specific responses of the histone acetylome to systematic perturbation</article-title><source>Mol Cell</source><year>2015</year><volume>57</volume><fpage>559</fpage><lpage>571</lpage><pub-id pub-id-type="pmid">25578876</pub-id></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ciurciu</surname><given-names>A</given-names></name><name><surname>Komonyi</surname><given-names>O</given-names></name><name><surname>Pankotai</surname><given-names>T</given-names></name><name><surname>Boros</surname><given-names>IM</given-names></name></person-group><article-title>The Drosophila histone acetyltransferase Gcn5 and transcriptional adaptor Ada2a are involved in nucleosomal histone H4 acetylation</article-title><source>Mol Cell Biol</source><year>2006</year><volume>26</volume><fpage>9413</fpage><lpage>9423</lpage><pub-id pub-id-type="pmcid">PMC1698533</pub-id><pub-id pub-id-type="pmid">17030603</pub-id><pub-id pub-id-type="doi">10.1128/MCB.01401-06</pub-id></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guelman</surname><given-names>S</given-names></name><name><surname>Kozuka</surname><given-names>K</given-names></name><name><surname>Mao</surname><given-names>Y</given-names></name><name><surname>Pham</surname><given-names>V</given-names></name><name><surname>Solloway</surname><given-names>MJ</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Lill</surname><given-names>JR</given-names></name><name><surname>Zha</surname><given-names>J</given-names></name></person-group><article-title>The double-histone-acetyltransferase complex ATAC is essential for mammalian development</article-title><source>Mol Cell Biol</source><year>2009</year><volume>29</volume><fpage>1176</fpage><lpage>1188</lpage><pub-id pub-id-type="pmcid">PMC2643826</pub-id><pub-id pub-id-type="pmid">19103755</pub-id><pub-id pub-id-type="doi">10.1128/MCB.01599-08</pub-id></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagy</surname><given-names>Z</given-names></name><name><surname>Riss</surname><given-names>A</given-names></name><name><surname>Fujiyama</surname><given-names>S</given-names></name><name><surname>Krebs</surname><given-names>A</given-names></name><name><surname>Orpinell</surname><given-names>M</given-names></name><name><surname>Jansen</surname><given-names>P</given-names></name><name><surname>Cohen</surname><given-names>A</given-names></name><name><surname>Stunnenberg</surname><given-names>HG</given-names></name><name><surname>Kato</surname><given-names>S</given-names></name><name><surname>Tora</surname><given-names>L</given-names></name></person-group><article-title>The metazoan ATAC and SAGA coactivator HAT complexes regulate different sets of inducible target genes</article-title><source>Cell Mol Life Sci</source><year>2010</year><volume>67</volume><fpage>611</fpage><lpage>628</lpage><pub-id pub-id-type="pmid">19936620</pub-id></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pankotai</surname><given-names>T</given-names></name><name><surname>Komonyi</surname><given-names>O</given-names></name><name><surname>Bodai</surname><given-names>L</given-names></name><name><surname>Ujfaludi</surname><given-names>Z</given-names></name><name><surname>Muratoglu</surname><given-names>S</given-names></name><name><surname>Ciurciu</surname><given-names>A</given-names></name><name><surname>Tora</surname><given-names>L</given-names></name><name><surname>Szabad</surname><given-names>J</given-names></name><name><surname>Boros</surname><given-names>I</given-names></name></person-group><article-title>The homologous Drosophila transcriptional adaptors ADA2a and ADA2b are both required for normal development but have different functions</article-title><source>Mol Cell Biol</source><year>2005</year><volume>25</volume><fpage>8215</fpage><lpage>8227</lpage><pub-id pub-id-type="pmcid">PMC1234310</pub-id><pub-id pub-id-type="pmid">16135810</pub-id><pub-id pub-id-type="doi">10.1128/MCB.25.18.8215-8227.2005</pub-id></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suganuma</surname><given-names>T</given-names></name><name><surname>Gutiérrez</surname><given-names>JL</given-names></name><name><surname>Li</surname><given-names>B</given-names></name><name><surname>Florens</surname><given-names>L</given-names></name><name><surname>Swanson</surname><given-names>SK</given-names></name><name><surname>Washburn</surname><given-names>MP</given-names></name><name><surname>Abmayr</surname><given-names>SM</given-names></name><name><surname>Workman</surname><given-names>JL</given-names></name></person-group><article-title>ATAC is a double histone acetyltransferase complex that stimulates nucleosome sliding</article-title><source>Nat Struct Mol Biol</source><year>2008</year><volume>15</volume><fpage>364</fpage><lpage>372</lpage><pub-id pub-id-type="pmid">18327268</pub-id></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fournier</surname><given-names>M</given-names></name><name><surname>Orpinell</surname><given-names>M</given-names></name><name><surname>Grauffel</surname><given-names>C</given-names></name><name><surname>Scheer</surname><given-names>E</given-names></name><name><surname>Garnier</surname><given-names>J-M</given-names></name><name><surname>Ye</surname><given-names>T</given-names></name><name><surname>Chavant</surname><given-names>V</given-names></name><name><surname>Joint</surname><given-names>M</given-names></name><name><surname>Esashi</surname><given-names>F</given-names></name><name><surname>Dejaegere</surname><given-names>A</given-names></name><etal/></person-group><article-title>KAT2A/KAT2B-targeted acetylome reveals a role for PLK4 acetylation in preventing centrosome amplification</article-title><source>Nat Commun</source><year>2016</year><volume>7</volume><elocation-id>13227</elocation-id><pub-id pub-id-type="pmcid">PMC5095585</pub-id><pub-id pub-id-type="pmid">27796307</pub-id><pub-id pub-id-type="doi">10.1038/ncomms13227</pub-id></element-citation></ref><ref id="R29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirsch</surname><given-names>CL</given-names></name><name><surname>Coban Akdemir</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Jayakumaran</surname><given-names>G</given-names></name><name><surname>Trcka</surname><given-names>D</given-names></name><name><surname>Weiss</surname><given-names>A</given-names></name><name><surname>Hernandez</surname><given-names>JJ</given-names></name><name><surname>Pan</surname><given-names>Q</given-names></name><name><surname>Han</surname><given-names>H</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><etal/></person-group><article-title>Myc and SAGA rewire an alternative splicing network during early somatic cell reprogramming</article-title><source>Genes Dev</source><year>2015</year><volume>29</volume><fpage>803</fpage><lpage>816</lpage><pub-id pub-id-type="pmcid">PMC4403257</pub-id><pub-id pub-id-type="pmid">25877919</pub-id><pub-id pub-id-type="doi">10.1101/gad.255109.114</pub-id></element-citation></ref><ref id="R30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krebs</surname><given-names>AR</given-names></name><name><surname>Karmodiya</surname><given-names>K</given-names></name><name><surname>Lindahl-Allen</surname><given-names>M</given-names></name><name><surname>Struhl</surname><given-names>K</given-names></name><name><surname>Tora</surname><given-names>L</given-names></name></person-group><article-title>SAGA and ATAC histone acetyl transferase complexes regulate distinct sets of genes and ATAC defines a class of p300-independent enhancers</article-title><source>Mol Cell</source><year>2011</year><volume>44</volume><fpage>410</fpage><lpage>423</lpage><pub-id pub-id-type="pmcid">PMC4641564</pub-id><pub-id pub-id-type="pmid">22055187</pub-id><pub-id pub-id-type="doi">10.1016/j.molcel.2011.08.037</pub-id></element-citation></ref><ref id="R31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagy</surname><given-names>Z</given-names></name><name><surname>Riss</surname><given-names>A</given-names></name><name><surname>Romier</surname><given-names>C</given-names></name><name><surname>le Guezennec</surname><given-names>X</given-names></name><name><surname>Dongre</surname><given-names>AR</given-names></name><name><surname>Orpinell</surname><given-names>M</given-names></name><name><surname>Han</surname><given-names>J</given-names></name><name><surname>Stunnenberg</surname><given-names>H</given-names></name><name><surname>Tora</surname><given-names>L</given-names></name></person-group><article-title>The human SPT20-containing SAGA complex plays a direct role in the regulation of endoplasmic reticulum stress-induced genes</article-title><source>Mol Cell Biol</source><year>2009</year><volume>29</volume><fpage>1649</fpage><lpage>1660</lpage><pub-id pub-id-type="pmcid">PMC2648226</pub-id><pub-id pub-id-type="pmid">19114550</pub-id><pub-id pub-id-type="doi">10.1128/MCB.01076-08</pub-id></element-citation></ref><ref id="R32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orpinell</surname><given-names>M</given-names></name><name><surname>Fournier</surname><given-names>M</given-names></name><name><surname>Riss</surname><given-names>A</given-names></name><name><surname>Nagy</surname><given-names>Z</given-names></name><name><surname>Krebs</surname><given-names>AR</given-names></name><name><surname>Frontini</surname><given-names>M</given-names></name><name><surname>Tora</surname><given-names>L</given-names></name></person-group><article-title>The ATAC acetyl transferase complex controls mitotic progression by targeting non-histone substrates</article-title><source>EMBO J</source><year>2010</year><volume>29</volume><fpage>2381</fpage><lpage>2394</lpage><pub-id pub-id-type="pmcid">PMC2910275</pub-id><pub-id pub-id-type="pmid">20562830</pub-id><pub-id pub-id-type="doi">10.1038/emboj.2010.125</pub-id></element-citation></ref><ref id="R33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stegeman</surname><given-names>R</given-names></name><name><surname>Spreacker</surname><given-names>PJ</given-names></name><name><surname>Swanson</surname><given-names>SK</given-names></name><name><surname>Stephenson</surname><given-names>R</given-names></name><name><surname>Florens</surname><given-names>L</given-names></name><name><surname>Washburn</surname><given-names>MP</given-names></name><name><surname>Weake</surname><given-names>VM</given-names></name></person-group><article-title>The Spliceosomal Protein SF3B5 is a Novel Component of Drosophila SAGA that Functions in Gene Expression Independent of Splicing</article-title><source>J Mol Biol</source><year>2016</year><volume>428</volume><fpage>3632</fpage><lpage>3649</lpage><pub-id pub-id-type="pmcid">PMC5011000</pub-id><pub-id pub-id-type="pmid">27185460</pub-id><pub-id pub-id-type="doi">10.1016/j.jmb.2016.05.009</pub-id></element-citation></ref><ref id="R34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fischer</surname><given-names>V</given-names></name><name><surname>Plassard</surname><given-names>D</given-names></name><name><surname>Ye</surname><given-names>T</given-names></name><name><surname>San Martin</surname><given-names>BR</given-names></name><name><surname>Stierle</surname><given-names>M</given-names></name><name><surname>Tora</surname><given-names>L</given-names></name><name><surname>Devys</surname><given-names>D</given-names></name></person-group><article-title>Two Related Coactivator Complexes SAGA and ATAC Control Embryonic Stem Cell Self-Renewal Through Two Different Acetyltransferase-Independent Mechanisms</article-title><source>SSRN Electron J</source><year>2021</year><pub-id pub-id-type="pmcid">PMC8430043</pub-id><pub-id pub-id-type="pmid">34433046</pub-id><pub-id pub-id-type="doi">10.1016/j.celrep.2021.109598</pub-id></element-citation></ref><ref id="R35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herbst</surname><given-names>DA</given-names></name><name><surname>Esbin</surname><given-names>MN</given-names></name><name><surname>Louder</surname><given-names>RK</given-names></name><name><surname>Dugast-Darzacq</surname><given-names>C</given-names></name><name><surname>Dailey</surname><given-names>GM</given-names></name><name><surname>Fang</surname><given-names>Q</given-names></name><name><surname>Darzacq</surname><given-names>X</given-names></name><name><surname>Tjian</surname><given-names>R</given-names></name><name><surname>Nogales</surname><given-names>E</given-names></name></person-group><article-title>Structure of the human SAGA coactivator complex</article-title><source>Nat Struct Mol Biol</source><year>2021</year><volume>28</volume><fpage>989</fpage><lpage>996</lpage></element-citation></ref><ref id="R36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soffers</surname><given-names>JHM</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Saraf</surname><given-names>A</given-names></name><name><surname>Seidel</surname><given-names>CW</given-names></name><name><surname>Florens</surname><given-names>L</given-names></name><name><surname>Washburn</surname><given-names>MP</given-names></name><name><surname>Abmayr</surname><given-names>SM</given-names></name><name><surname>Workman</surname><given-names>JL</given-names></name></person-group><article-title>Characterization of a metazoan ADA acetyltransferase complex</article-title><source>Nucleic Acids Res</source><year>2019</year><volume>47</volume><fpage>3383</fpage><lpage>3394</lpage><pub-id pub-id-type="pmcid">PMC6468242</pub-id><pub-id pub-id-type="pmid">30715476</pub-id><pub-id pub-id-type="doi">10.1093/nar/gkz042</pub-id></element-citation></ref><ref id="R37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torres-Zelada</surname><given-names>EF</given-names></name><name><surname>Stephenson</surname><given-names>RE</given-names></name><name><surname>Alpsoy</surname><given-names>A</given-names></name><name><surname>Anderson</surname><given-names>BD</given-names></name><name><surname>Swanson</surname><given-names>SK</given-names></name><name><surname>Florens</surname><given-names>L</given-names></name><name><surname>Dykhuizen</surname><given-names>EC</given-names></name><name><surname>Washburn</surname><given-names>MP</given-names></name><name><surname>Weake</surname><given-names>VM</given-names></name></person-group><article-title>The Drosophila Dbf4 ortholog Chiffon forms a complex with Gcn5 that is necessary for histone acetylation and viability</article-title><source>J Cell Sci</source><year>2019</year><volume>132</volume><elocation-id>jcs214072</elocation-id><pub-id pub-id-type="pmcid">PMC6362396</pub-id><pub-id pub-id-type="pmid">30559249</pub-id><pub-id pub-id-type="doi">10.1242/jcs.214072</pub-id></element-citation></ref><ref id="R38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheon</surname><given-names>Y</given-names></name><name><surname>Kim</surname><given-names>H</given-names></name><name><surname>Park</surname><given-names>K</given-names></name><name><surname>Kim</surname><given-names>M</given-names></name><name><surname>Lee</surname><given-names>D</given-names></name></person-group><article-title>Dynamic modules of the coactivator SAGA in eukaryotic transcription</article-title><source>Exp Mol Med</source><year>2020</year><volume>52</volume><fpage>991</fpage><lpage>1003</lpage><pub-id pub-id-type="pmcid">PMC8080568</pub-id><pub-id pub-id-type="pmid">32616828</pub-id><pub-id pub-id-type="doi">10.1038/s12276-020-0463-4</pub-id></element-citation></ref><ref id="R39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McMahon</surname><given-names>SB</given-names></name><name><surname>Van Buskirk</surname><given-names>HA</given-names></name><name><surname>Dugan</surname><given-names>KA</given-names></name><name><surname>Copeland</surname><given-names>TD</given-names></name><name><surname>Cole</surname><given-names>MD</given-names></name></person-group><article-title>The novel ATM-related protein TRRAP is an essential cofactor for the c-Myc and E2F oncoproteins</article-title><source>Cell</source><year>1998</year><volume>94</volume><fpage>363</fpage><lpage>374</lpage><pub-id pub-id-type="pmid">9708738</pub-id></element-citation></ref><ref id="R40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McMahon</surname><given-names>SB</given-names></name><name><surname>Wood</surname><given-names>MA</given-names></name><name><surname>Cole</surname><given-names>MD</given-names></name></person-group><article-title>The essential cofactor TRRAP recruits the histone acetyltransferase hGCN5 to c-Myc</article-title><source>Mol Cell Biol</source><year>2000</year><volume>20</volume><fpage>556</fpage><lpage>562</lpage><pub-id pub-id-type="pmcid">PMC85131</pub-id><pub-id pub-id-type="pmid">10611234</pub-id><pub-id pub-id-type="doi">10.1128/mcb.20.2.556-562.2000</pub-id></element-citation></ref><ref id="R41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>N</given-names></name><name><surname>Ichikawa</surname><given-names>W</given-names></name><name><surname>Faiola</surname><given-names>F</given-names></name><name><surname>Lo</surname><given-names>S-Y</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Martinez</surname><given-names>E</given-names></name></person-group><article-title>MYC interacts with the human STAGA coactivator complex via multivalent contacts with the GCN5 and TRRAP subunits</article-title><source>Biochim Biophys Acta</source><year>2014</year><volume>1839</volume><fpage>395</fpage><lpage>405</lpage><pub-id pub-id-type="pmcid">PMC4039629</pub-id><pub-id pub-id-type="pmid">24705139</pub-id><pub-id pub-id-type="doi">10.1016/j.bbagrm.2014.03.017</pub-id></element-citation></ref><ref id="R42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Tesfai</surname><given-names>J</given-names></name><name><surname>Evrard</surname><given-names>YA</given-names></name><name><surname>Dent</surname><given-names>SYR</given-names></name><name><surname>Martinez</surname><given-names>E</given-names></name></person-group><article-title>c-Myc transformation domain recruits the human STAGA complex and requires TRRAP and GCN5 acetylase activity for transcription activation</article-title><source>J Biol Chem</source><year>2003</year><volume>278</volume><fpage>20405</fpage><lpage>20412</lpage><pub-id pub-id-type="pmcid">PMC4031917</pub-id><pub-id pub-id-type="pmid">12660246</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M211795200</pub-id></element-citation></ref><ref id="R43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>North</surname><given-names>JA</given-names></name><name><surname>Shimko</surname><given-names>JC</given-names></name><name><surname>Javaid</surname><given-names>S</given-names></name><name><surname>Mooney</surname><given-names>AM</given-names></name><name><surname>Shoffner</surname><given-names>MA</given-names></name><name><surname>Rose</surname><given-names>SD</given-names></name><name><surname>Bundschuh</surname><given-names>R</given-names></name><name><surname>Fishel</surname><given-names>R</given-names></name><name><surname>Ottesen</surname><given-names>JJ</given-names></name><name><surname>Poirier</surname><given-names>MG</given-names></name></person-group><article-title>Regulation of the nucleosome unwrapping rate controls DNA accessibility</article-title><source>Nucleic Acids Res</source><year>2012</year><volume>40</volume><fpage>10215</fpage><lpage>10227</lpage><pub-id pub-id-type="pmcid">PMC3488218</pub-id><pub-id pub-id-type="pmid">22965129</pub-id><pub-id pub-id-type="doi">10.1093/nar/gks747</pub-id></element-citation></ref><ref id="R44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koerber</surname><given-names>RT</given-names></name><name><surname>Rhee</surname><given-names>HS</given-names></name><name><surname>Jiang</surname><given-names>C</given-names></name><name><surname>Pugh</surname><given-names>BF</given-names></name></person-group><article-title>Interaction of transcriptional regulators with specific nucleosomes across the Saccharomyces genome</article-title><source>Mol Cell</source><year>2009</year><volume>35</volume><fpage>889</fpage><lpage>902</lpage><pub-id pub-id-type="pmcid">PMC2760215</pub-id><pub-id pub-id-type="pmid">19782036</pub-id><pub-id pub-id-type="doi">10.1016/j.molcel.2009.09.011</pub-id></element-citation></ref><ref id="R45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Michael</surname><given-names>AK</given-names></name><name><surname>Stoos</surname><given-names>L</given-names></name><name><surname>Crosby</surname><given-names>P</given-names></name><name><surname>Eggers</surname><given-names>N</given-names></name><name><surname>Nie</surname><given-names>XY</given-names></name><name><surname>Makasheva</surname><given-names>K</given-names></name><name><surname>Minnich</surname><given-names>M</given-names></name><name><surname>Healy</surname><given-names>KL</given-names></name><name><surname>Weiss</surname><given-names>J</given-names></name><name><surname>Kempf</surname><given-names>G</given-names></name><etal/></person-group><article-title>Cooperation between bHLH transcription factors and histones for DNA access</article-title><source>Nature</source><year>2023</year><volume>619</volume><fpage>385</fpage><lpage>393</lpage><pub-id pub-id-type="pmcid">PMC10338342</pub-id><pub-id pub-id-type="pmid">37407816</pub-id><pub-id pub-id-type="doi">10.1038/s41586-023-06282-3</pub-id></element-citation></ref><ref id="R46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname><given-names>Y</given-names></name><name><surname>North</surname><given-names>JA</given-names></name><name><surname>Poirier</surname><given-names>MG</given-names></name></person-group><article-title>Single molecule fluorescence methodologies for investigating transcription factor binding kinetics to nucleosomes and DNA</article-title><source>Methods</source><year>2014</year><volume>70</volume><fpage>108</fpage><lpage>118</lpage><pub-id pub-id-type="pmcid">PMC5484159</pub-id><pub-id pub-id-type="pmid">25304387</pub-id><pub-id pub-id-type="doi">10.1016/j.ymeth.2014.09.011</pub-id></element-citation></ref><ref id="R47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>JD</given-names></name><name><surname>Widom</surname><given-names>J</given-names></name></person-group><article-title>Sequence and position-dependence of the equilibrium accessibility of nucleosomal DNA target sites</article-title><source>J Mol Biol</source><year>2000</year><volume>296</volume><fpage>979</fpage><lpage>987</lpage><pub-id pub-id-type="pmid">10686097</pub-id></element-citation></ref><ref id="R48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>SD</given-names></name><name><surname>Marmorstein</surname><given-names>R</given-names></name><name><surname>Harrison</surname><given-names>SC</given-names></name><name><surname>Ptashne</surname><given-names>M</given-names></name></person-group><article-title>DNA sequence preferences of GAL4 and PPR1: how a subset of Zn2 Cys6 binuclear cluster proteins recognizes DNA</article-title><source>Mol Cell Biol</source><year>1996</year><volume>16</volume><fpage>3773</fpage><lpage>3780</lpage><pub-id pub-id-type="pmcid">PMC231373</pub-id><pub-id pub-id-type="pmid">8668194</pub-id><pub-id pub-id-type="doi">10.1128/mcb.16.7.3773</pub-id></element-citation></ref><ref id="R49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bernier</surname><given-names>M</given-names></name><name><surname>Luo</surname><given-names>Y</given-names></name><name><surname>Nwokelo</surname><given-names>KC</given-names></name><name><surname>Goodwin</surname><given-names>M</given-names></name><name><surname>Dreher</surname><given-names>SJ</given-names></name><name><surname>Zhang</surname><given-names>P</given-names></name><name><surname>Parthun</surname><given-names>MR</given-names></name><name><surname>Fondufe-Mittendorf</surname><given-names>Y</given-names></name><name><surname>Ottesen</surname><given-names>JJ</given-names></name><name><surname>Poirier</surname><given-names>MG</given-names></name></person-group><article-title>Linker histone H1 and H3K56 acetylation are antagonistic regulators of nucleosome dynamics</article-title><source>Nat Commun</source><year>2015</year><volume>6</volume><elocation-id>10152</elocation-id><pub-id pub-id-type="pmcid">PMC4682114</pub-id><pub-id pub-id-type="pmid">26648124</pub-id><pub-id pub-id-type="doi">10.1038/ncomms10152</pub-id></element-citation></ref><ref id="R50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burge</surname><given-names>NL</given-names></name><name><surname>Thuma</surname><given-names>JL</given-names></name><name><surname>Hong</surname><given-names>ZZ</given-names></name><name><surname>Jamison</surname><given-names>KB</given-names></name><name><surname>Ottesen</surname><given-names>JJ</given-names></name><name><surname>Poirier</surname><given-names>MG</given-names></name></person-group><article-title>H1.0 C Terminal Domain Is Integral for Altering Transcription Factor Binding within Nucleosomes</article-title><source>Biochemistry</source><year>2022</year><volume>61</volume><fpage>625</fpage><lpage>638</lpage><pub-id pub-id-type="pmcid">PMC9022651</pub-id><pub-id pub-id-type="pmid">35377618</pub-id><pub-id pub-id-type="doi">10.1021/acs.biochem.2c00001</pub-id></element-citation></ref><ref id="R51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shimko</surname><given-names>JC</given-names></name><name><surname>North</surname><given-names>JA</given-names></name><name><surname>Bruns</surname><given-names>AN</given-names></name><name><surname>Poirier</surname><given-names>MG</given-names></name><name><surname>Ottesen</surname><given-names>JJ</given-names></name></person-group><article-title>Preparation of fully synthetic histone H3 reveals that acetyl-lysine 56 facilitates protein binding within nucleosomes</article-title><source>J Mol Biol</source><year>2011</year><volume>408</volume><fpage>187</fpage><lpage>204</lpage><pub-id pub-id-type="pmcid">PMC3815667</pub-id><pub-id pub-id-type="pmid">21310161</pub-id><pub-id pub-id-type="doi">10.1016/j.jmb.2011.01.003</pub-id></element-citation></ref><ref id="R52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luger</surname><given-names>K</given-names></name><name><surname>Rechsteiner</surname><given-names>TJ</given-names></name><name><surname>Richmond</surname><given-names>TJ</given-names></name></person-group><article-title>Expression and purification of recombinant histones and nucleosome reconstitution</article-title><source>Methods Mol Biol Clifton NJ</source><year>1999</year><volume>119</volume><fpage>1</fpage><lpage>16</lpage><pub-id pub-id-type="pmid">10804500</pub-id></element-citation></ref><ref id="R53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname><given-names>M</given-names></name><name><surname>Fitzgerald</surname><given-names>MX</given-names></name><name><surname>Harper</surname><given-names>S</given-names></name><name><surname>Luo</surname><given-names>C</given-names></name><name><surname>Speicher</surname><given-names>DW</given-names></name><name><surname>Marmorstein</surname><given-names>R</given-names></name></person-group><article-title>Structural basis for dimerization in DNA recognition by Gal4</article-title><source>Struct Lond Engl</source><year>2008</year><volume>1993</volume><issue>16</issue><fpage>1019</fpage><lpage>1026</lpage><pub-id pub-id-type="pmcid">PMC2515386</pub-id><pub-id pub-id-type="pmid">18611375</pub-id><pub-id pub-id-type="doi">10.1016/j.str.2008.03.015</pub-id></element-citation></ref><ref id="R54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sadowski</surname><given-names>I</given-names></name><name><surname>Ma</surname><given-names>J</given-names></name><name><surname>Triezenbergt</surname><given-names>S</given-names></name><name><surname>Ptashne</surname><given-names>M</given-names></name></person-group><article-title>GAL4-VP16 is an unusually potent transcriptional activator</article-title><volume>335</volume><fpage>16</fpage><lpage>17</lpage><pub-id pub-id-type="pmid">3047590</pub-id></element-citation></ref><ref id="R55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berger</surname><given-names>I</given-names></name><name><surname>Fitzgerald</surname><given-names>DJ</given-names></name><name><surname>Richmond</surname><given-names>TJ</given-names></name></person-group><article-title>Baculovirus expression system for heterologous multiprotein complexes</article-title><source>Nat Biotechnol</source><year>2004</year><volume>22</volume><fpage>1583</fpage><lpage>1587</lpage><pub-id pub-id-type="pmid">15568020</pub-id></element-citation></ref><ref id="R56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trowitzsch</surname><given-names>S</given-names></name><name><surname>Bieniossek</surname><given-names>C</given-names></name><name><surname>Nie</surname><given-names>Y</given-names></name><name><surname>Garzoni</surname><given-names>F</given-names></name><name><surname>Berger</surname><given-names>I</given-names></name></person-group><article-title>New baculovirus expression tools for recombinant protein complex production</article-title><source>J Struct Biol</source><year>2010</year><volume>172</volume><fpage>45</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">20178849</pub-id></element-citation></ref><ref id="R57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clegg</surname><given-names>RM</given-names></name></person-group><article-title>Fluorescence resonance energy transfer</article-title><source>Curr Opin Biotechnol</source><year>1995</year><volume>6</volume><fpage>103</fpage><lpage>110</lpage><pub-id pub-id-type="pmid">7534502</pub-id></element-citation></ref><ref id="R58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tencer</surname><given-names>AH</given-names></name><name><surname>Cox</surname><given-names>KL</given-names></name><name><surname>Di</surname><given-names>L</given-names></name><name><surname>Bridgers</surname><given-names>JB</given-names></name><name><surname>Lyu</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Sims</surname><given-names>JK</given-names></name><name><surname>Weaver</surname><given-names>TM</given-names></name><name><surname>Allen</surname><given-names>HF</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Covalent Modifications of Histone H3K9 Promote Binding of CHD3</article-title><source>Cell Rep</source><year>2017</year><volume>21</volume><fpage>455</fpage><lpage>466</lpage><pub-id pub-id-type="pmcid">PMC5653232</pub-id><pub-id pub-id-type="pmid">29020631</pub-id><pub-id pub-id-type="doi">10.1016/j.celrep.2017.09.054</pub-id></element-citation></ref><ref id="R59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Canzio</surname><given-names>D</given-names></name><name><surname>Liao</surname><given-names>M</given-names></name><name><surname>Naber</surname><given-names>N</given-names></name><name><surname>Pate</surname><given-names>E</given-names></name><name><surname>Larson</surname><given-names>A</given-names></name><name><surname>Wu</surname><given-names>S</given-names></name><name><surname>Marina</surname><given-names>DB</given-names></name><name><surname>Garcia</surname><given-names>JF</given-names></name><name><surname>Madhani</surname><given-names>HD</given-names></name><name><surname>Cooke</surname><given-names>R</given-names></name><etal/></person-group><article-title>A conformational switch in HP1 releases auto-inhibition to drive heterochromatin assembly</article-title><source>Nature</source><year>2013</year><volume>496</volume><fpage>377</fpage><lpage>381</lpage><pub-id pub-id-type="pmcid">PMC3907283</pub-id><pub-id pub-id-type="pmid">23485968</pub-id><pub-id pub-id-type="doi">10.1038/nature12032</pub-id></element-citation></ref><ref id="R60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hardy</surname><given-names>S</given-names></name><name><surname>Brand</surname><given-names>M</given-names></name><name><surname>Mittler</surname><given-names>G</given-names></name><name><surname>Yanagisawa</surname><given-names>J</given-names></name><name><surname>Kato</surname><given-names>S</given-names></name><name><surname>Meisterernst</surname><given-names>M</given-names></name><name><surname>Tora</surname><given-names>L</given-names></name></person-group><article-title>TATA-binding protein-free TAF-containing complex (TFTC) and p300 are both required for efficient transcriptional activation</article-title><source>J Biol Chem</source><year>2002</year><volume>277</volume><fpage>32875</fpage><lpage>32882</lpage><pub-id pub-id-type="pmid">12107188</pub-id></element-citation></ref><ref id="R61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brand</surname><given-names>M</given-names></name><name><surname>Moggs</surname><given-names>JG</given-names></name><name><surname>Oulad-Abdelghani</surname><given-names>M</given-names></name><name><surname>Lejeune</surname><given-names>F</given-names></name><name><surname>Dilworth</surname><given-names>FJ</given-names></name><name><surname>Stevenin</surname><given-names>J</given-names></name><name><surname>Almouzni</surname><given-names>G</given-names></name><name><surname>Tora</surname><given-names>L</given-names></name></person-group><article-title>UV-damaged DNA-binding protein in the TFTC complex links DNA damage recognition to nucleosome acetylation</article-title><source>EMBO J</source><year>2001</year><volume>20</volume><fpage>3187</fpage><lpage>3196</lpage><pub-id pub-id-type="pmcid">PMC150203</pub-id><pub-id pub-id-type="pmid">11406595</pub-id><pub-id pub-id-type="doi">10.1093/emboj/20.12.3187</pub-id></element-citation></ref><ref id="R62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>White</surname><given-names>J</given-names></name><name><surname>Brou</surname><given-names>C</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Lutz</surname><given-names>Y</given-names></name><name><surname>Moncollin</surname><given-names>V</given-names></name><name><surname>Chambon</surname><given-names>P</given-names></name></person-group><article-title>The acidic transcriptional activator GAL-VP16 acts on preformed template-committed complexes</article-title><source>EMBO J</source><year>1992</year><volume>11</volume><fpage>2229</fpage><lpage>2240</lpage><pub-id pub-id-type="pmcid">PMC556690</pub-id><pub-id pub-id-type="pmid">1376247</pub-id><pub-id pub-id-type="doi">10.1002/j.1460-2075.1992.tb05282.x</pub-id></element-citation></ref><ref id="R63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanner</surname><given-names>KG</given-names></name><name><surname>Trievel</surname><given-names>RC</given-names></name><name><surname>Kuo</surname><given-names>M-H</given-names></name><name><surname>Howard</surname><given-names>RM</given-names></name><name><surname>Berger</surname><given-names>SL</given-names></name><name><surname>Allis</surname><given-names>CD</given-names></name><name><surname>Marmorstein</surname><given-names>R</given-names></name><name><surname>Denu</surname><given-names>JM</given-names></name></person-group><article-title>Catalytic Mechanism and Function of Invariant Glutamic Acid 173 from the Histone Acetyltransferase GCN5 Transcriptional Coactivator*</article-title><source>J Biol Chem</source><year>1999</year><volume>274</volume><fpage>18157</fpage><lpage>18160</lpage><pub-id pub-id-type="pmid">10373413</pub-id></element-citation></ref><ref id="R64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Musselman</surname><given-names>CA</given-names></name><name><surname>Gibson</surname><given-names>MD</given-names></name><name><surname>Hartwick</surname><given-names>EW</given-names></name><name><surname>North</surname><given-names>JA</given-names></name><name><surname>Gatchalian</surname><given-names>J</given-names></name><name><surname>Poirier</surname><given-names>MG</given-names></name><name><surname>Kutateladze</surname><given-names>TG</given-names></name></person-group><article-title>Binding of PHF1 Tudor to H3K36me3 enhances nucleosome accessibility</article-title><source>Nat Commun</source><year>2013</year><volume>4</volume><pub-id pub-id-type="pmcid">PMC4007151</pub-id><pub-id pub-id-type="pmid">24352064</pub-id><pub-id pub-id-type="doi">10.1038/ncomms3969</pub-id></element-citation></ref><ref id="R65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>G</given-names></name><name><surname>Widom</surname><given-names>J</given-names></name></person-group><article-title>Nucleosomes facilitate their own invasion</article-title><source>Nat Struct Mol Biol</source><year>2004</year><volume>11</volume><fpage>763</fpage><lpage>769</lpage><pub-id pub-id-type="pmid">15258568</pub-id></element-citation></ref><ref id="R66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhaumik</surname><given-names>SR</given-names></name><name><surname>Raha</surname><given-names>T</given-names></name><name><surname>Aiello</surname><given-names>DP</given-names></name><name><surname>Green</surname><given-names>MR</given-names></name></person-group><article-title>In vivo target of a transcriptional activator revealed by fluorescence resonance energy transfer</article-title><source>Genes Dev</source><year>2004</year><volume>18</volume><fpage>333</fpage><lpage>343</lpage><pub-id pub-id-type="pmcid">PMC338285</pub-id><pub-id pub-id-type="pmid">14871930</pub-id><pub-id pub-id-type="doi">10.1101/gad.1148404</pub-id></element-citation></ref><ref id="R67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>G</given-names></name><name><surname>Levitus</surname><given-names>M</given-names></name><name><surname>Bustamante</surname><given-names>C</given-names></name><name><surname>Widom</surname><given-names>J</given-names></name></person-group><article-title>Rapid spontaneous accessibility of nucleosomal DNA</article-title><source>Nat Struct Mol Biol</source><year>2005</year><volume>12</volume><fpage>46</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">15580276</pub-id></element-citation></ref><ref id="R68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fischer</surname><given-names>V</given-names></name><name><surname>Schumacher</surname><given-names>K</given-names></name><name><surname>Tora</surname><given-names>L</given-names></name><name><surname>Devys</surname><given-names>D</given-names></name></person-group><article-title>Global role for coactivator complexes in RNA polymerase II transcription</article-title><source>Transcription</source><year>2019</year><volume>10</volume><fpage>29</fpage><lpage>36</lpage><pub-id pub-id-type="pmcid">PMC6351120</pub-id><pub-id pub-id-type="pmid">30299209</pub-id><pub-id pub-id-type="doi">10.1080/21541264.2018.1521214</pub-id></element-citation></ref><ref id="R69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Göös</surname><given-names>H</given-names></name><name><surname>Kinnunen</surname><given-names>M</given-names></name><name><surname>Salokas</surname><given-names>K</given-names></name><name><surname>Tan</surname><given-names>Z</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Yadav</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Wei</surname><given-names>G-H</given-names></name><name><surname>Varjosalo</surname><given-names>M</given-names></name></person-group><article-title>Human transcription factor protein interaction networks</article-title><source>Nat Commun</source><year>2022</year><volume>13</volume><elocation-id>766</elocation-id><pub-id pub-id-type="pmcid">PMC8828895</pub-id><pub-id pub-id-type="pmid">35140242</pub-id><pub-id pub-id-type="doi">10.1038/s41467-022-28341-5</pub-id></element-citation></ref><ref id="R70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname><given-names>Y</given-names></name><name><surname>North</surname><given-names>JA</given-names></name><name><surname>Rose</surname><given-names>SD</given-names></name><name><surname>Poirier</surname><given-names>MG</given-names></name></person-group><article-title>Nucleosomes accelerate transcription factor dissociation</article-title><source>Nucleic Acids Res</source><year>2014</year><volume>42</volume><fpage>3017</fpage><lpage>3027</lpage><pub-id pub-id-type="pmcid">PMC3950707</pub-id><pub-id pub-id-type="pmid">24353316</pub-id><pub-id pub-id-type="doi">10.1093/nar/gkt1319</pub-id></element-citation></ref><ref id="R71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morgan</surname><given-names>MAJ</given-names></name><name><surname>Shilatifard</surname><given-names>A</given-names></name></person-group><article-title>Epigenetic moonlighting: Catalytic-independent functions of histone modifiers in regulating transcription</article-title><source>Sci Adv</source><year>2023</year><volume>9</volume><elocation-id>eadg6593</elocation-id><pub-id pub-id-type="pmcid">PMC10121172</pub-id><pub-id pub-id-type="pmid">37083523</pub-id><pub-id pub-id-type="doi">10.1126/sciadv.adg6593</pub-id></element-citation></ref><ref id="R72"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fischer</surname><given-names>V</given-names></name><name><surname>Plassard</surname><given-names>D</given-names></name><name><surname>Ye</surname><given-names>T</given-names></name><name><surname>Reina-San-Martin</surname><given-names>B</given-names></name><name><surname>Stierle</surname><given-names>M</given-names></name><name><surname>Tora</surname><given-names>L</given-names></name><name><surname>Devys</surname><given-names>D</given-names></name></person-group><article-title>The related coactivator complexes SAGA and ATAC control embryonic stem cell self-renewal through acetyltransferase-independent mechanisms</article-title><source>Cell Rep</source><year>2021</year><volume>36</volume><elocation-id>109598</elocation-id></element-citation></ref><ref id="R73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ciabrelli</surname><given-names>F</given-names></name><name><surname>Rabbani</surname><given-names>L</given-names></name><name><surname>Cardamone</surname><given-names>F</given-names></name><name><surname>Zenk</surname><given-names>F</given-names></name><name><surname>Löser</surname><given-names>E</given-names></name><name><surname>Schächtle</surname><given-names>MA</given-names></name><name><surname>Mazina</surname><given-names>M</given-names></name><name><surname>Loubiere</surname><given-names>V</given-names></name><name><surname>Iovino</surname><given-names>N</given-names></name></person-group><article-title>CBP and Gcn5 drive zygotic genome activation independently of their catalytic activity</article-title><source>Sci Adv</source><year>2023</year><volume>9</volume><elocation-id>eadf2687</elocation-id><pub-id pub-id-type="pmcid">PMC10121174</pub-id><pub-id pub-id-type="pmid">37083536</pub-id><pub-id pub-id-type="doi">10.1126/sciadv.adf2687</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" position="float"><label>Figure 1</label><caption><title>ATAC and SAGA HAT module organization and ATAC HAT module interactions with nucleosomes.</title><p>(A) Schematic representations of the shared subunits of the ATAC and SAGA HAT modules (KAT2A, SGF29 and TADA3), together with ADA2A and ADA2B, which are ATAC and SAGA subunits, respectively (<xref ref-type="bibr" rid="R10">10</xref>). PCAF: PCAF homology domain; AT: Acetyl-transferase domain; BROMO: bromo domain; ZF: zinc-finger domain; SANT: <underline>S</underline>wi3, <underline>A</underline>DA2, <underline>N</underline>-Cor and <underline>T</underline>FIIIB domain; Tudor: Tudor domain; CC: coiled coil domain. (B) (Upper part) Schematic of the DNA used in Fluorescence Polarization experiments. DNA is 252 bp long and consists of the Widom 601 sequence (light gray) flanked by a 30 bp (left, dark gray) and a 75 bp linker DNA (right, dark gray). Within the 601 sequence is a 19 bp Gal4 binding site (light blue) at 8-26 bp in the 601 nucleosome positioning sequence (NPS). Fluorescein (yellow) is attached to a modified thymine 4 bp into the 30 bp linker DNA away from the 601 NPS. (Lower part) Schematic of the DNA used in FRET experiments. Same sequence as above but with Cy3 (green) attached to a modified thymine 4 bp into the 30 bp linker DNA away from the 601 NPS. (C) Nucleosome structure (PDB 1KX5) indicating the estimated difference between Cy3 on the DNA (green) and Cy5 on H2A (magenta). The histone octamer is gray, DNA is dark gray, and Gal4 binding site is blue. (D) Fluorescence Polarization in mP of nucleosomes with increasing amounts of the ATAC<sub>HAT</sub> module. The ATAC<sub>HAT</sub> module binds with an S<sub>1/2</sub> of 23 ± 4 nM (blue square), reaching saturating conditions around 100 nM. The ATAC<sub>HAT</sub> module with Ac-CoA binds at a S<sub>1/2</sub> of 19.6 ± 0.6 nM (black diamond). (E) FRET efficiency of the Cy3-Cy5 labeled nucleosome with increasing concentrations of ATAC<sub>HAT</sub>.</p></caption><graphic xlink:href="EMS190329-f001"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><title>HAT module of SAGA and ATAC complexes directly interact with VP16 AD.</title><p>(A) Image of immunoblot input extracts containing non-infected SF9 cell extract (Control, lane 2), and SF9 cell extracts expressing the subunits of either ATAC<sub>HAT</sub>, or SAGA<sub>HAT</sub> (lane 3 and 4). Input extracts were incubated with either GST-VP16 (B) or GST (C) columns, washed and eluted. Elutions were resolved by SDS-PAGE and analyzed by Western blot with the indicated antibodies. Equal loading was tested by Coomassie brilliant blue staining of either GST-VP16 (B) or GST (C) protein containing beads.</p></caption><graphic xlink:href="EMS190329-f002"/></fig><fig id="F3" position="float"><label>Figure 3</label><caption><title>TFs interactions with nucleosomes.</title><p>(A) Schematic of TFs: Gal4-VP16 and Gal4-DBD. Gal4-VP16 contains the DNA binding domain and dimerization domain of Gal4 fused to the VP16 activator domain from the Herpes Simplex Virus. Gal4-DBD contains the DNA binding domain and dimerization domain of Gal4. (B) Schematic of Gal4-VP16 binding equilibrium to a partially unwrapped nucleosome. (C) Normalized ΔFRET (the asymptote of the beginning of the hill plot fit set to 1 and the asymptote of the ending of the fit is set to 0) of Gal4-VP16 (dark gray squares) and Gal4-DBD (light gray circles) binding nucleosomes at increasing amounts. Gal4-VP16 binds with an S<sub>1/2</sub> of 55 ± 2 nM and Gal4-DBD binds with an S<sub>1/2</sub> of 19 ± 1 nM. (D) Bar plot of S<sub>1/2</sub> and standard error values from the weighted fits to binding isotherms in C.</p></caption><graphic xlink:href="EMS190329-f003"/></fig><fig id="F4" position="float"><label>Figure 4</label><caption><title>Gal4-VP16 influences the acetylation of the SAGA HAT module.</title><p>Acetylation-coupled western blot assay of the ATAC<sub>HAT</sub> (A) and SAGA<sub>HAT</sub> (B) module at increasing concentrations with and without Gal4-VP16 at the indicated PTM sites. The fluorescence of Cy5-labeled histone H2A within the nucleosome was used to quantify nucleosome loading. Acetylation efficiency was tested by western blot using antibodies recognizing either histone H3K9ac, or H4K5ac. Images are representative of three independent experiments with similar results (<italic>n</italic> = 3). Two-tailed, unpaired t-test with Welch’s correction was conducted using Prism 9 software. Error bars represent standard error of the mean (SEM). (C,D) Bar plot of A. (E,F) Bar plot of B.</p></caption><graphic xlink:href="EMS190329-f004"/></fig><fig id="F5" position="float"><label>Figure 5</label><caption><title>ATAC<sub>HAT</sub> and SAGA<sub>HAT</sub> influence nucleosome accessibility to Gal4-VP16 binding independent of Ac-CoA.</title><p>(A) Model of Gal4-VP16 and the ATAC<sub>HAT</sub> module binding to a nucleosome. (B) Normalized ΔFRET of Gal4-VP16 binding nucleosomes with increasing amounts. Gal4-VP16 binding to nucleosomes at a S<sub>1/2</sub> of 55 ± 2 nM (dark gray circles), Gal4-VP16 binding to nucleosomes with the addition of 200 nM ATAC<sub>HAT</sub> at a S<sub>1/2</sub> of 5.3 ± 0.7 nM (dark blue squares), and with the addition of 30 uM Ac-CoA at a S<sub>1/2</sub> of 7 ± 1 nM (purple diamond). (C) Bar plot of the S<sub>1/2</sub> from B. (D) Model of Gal4-VP16 and the SAGA<sub>HAT</sub> module binding to a nucleosome. (E) Normalized ΔFRET of Gal4-VP16 binding to nucleosomes at increasing amounts. Gal4-VP16 binding to nucleosomes at a S<sub>1/2</sub> of 55 ± 2 nM (dark gray circles), Gal4-VP16 binding to nucleosomes with the addition of 150 nM SAGA<sub>HAT</sub> at a S<sub>1/2</sub> of 7 ± 1 nM (red triangles), and with the addition of 30 μM Ac-CoA at a S<sub>1/2</sub> of 6.5 ± 0.9 nM (purple diamond). (F) Bar plot of S<sub>1/2</sub> and standard error values from the weighted fits to binding isotherms in E.</p></caption><graphic xlink:href="EMS190329-f005"/></fig><fig id="F6" position="float"><label>Figure 6</label><caption><title>Models of HAT module and TF binding to a partially unwrapped nucleosome.</title><p>Model 1: Gal4-VP16 first binds to its recognition sequence and then recruits the HAT module. Model 2: Gal4-VP16 and the HAT module interact with each other first before binding the nucleosome together. Model 3: the HAT module interacts with the nucleosome first, allowing Gal4-VP16 to bind at a higher affinity. Since the impact of the HAT module on TF binding is acetylation independent, acetylation is not indicated in the model. However, histone acetylation will occur when the HAT module is bound to the nucleosome, which includes the fully bound nucleosome and the intermediate state of Model 3.</p></caption><graphic xlink:href="EMS190329-f006"/></fig></floats-group></article>